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ABSTRACT
Obstructive sleep apnoea syndrome (OSAS) is a general health problem which 
causes daytime sleepiness, impaired quality of life and increased morbidity and 
mortality. A narrow upper airway anatomy is a common cause of OSAS, and 
tracheostomy was the initial surgical treatment for OSAS. During the 1980s and 
1990s uvulopalatopharyngoplasty (UPPP) was the predominant treatment befo-
re continuous positive airway pressure (CPAP) and mandibular retaining devices 
(MRDs) became available in Sweden. The degree of evidence for the efficacy 
of surgical treatments, especially UPPP, has been very low so far. The results 
have also varied, depending on the selection of patients and the surgical method. 
Therefore, randomised controlled trials (RCTs) and long-term follow-up studies 
in this field have been called for. This thesis evaluates the long-term findings 
after UPPP in unselected patients, as well as tracheostomy and UPPP (modified, 
conservative technique) as treatments in selected OSAS patients who have failed 
other non-surgical treatments and therefore risk remaining untreated.
In Paper 1, a retrospective cohort study of 10 severe and obese OSAS patients, 
the tolerability of custom-made tracheostomy tubes, nocturnal respiration and 
excessive daytime sleepiness (EDS) symptoms were evaluated. Eigth tolerated 
the tube for more than 6 months. The oxygen desaturation index (ODI
4
)  de-
creased from 81 (range 55–126) to 13 (1–87) and EDS measured with the Ep-
worth Sleepiness Scale (ESS) was reduced from a median of 18 (8–23) to 5 
(0–7). Tracheostomy served as a link to other OSAS treatments. 
Paper 2 was a 15-year follow-up of 50 OSAS patients after UPPP. In all, 13 
patients had died; 26 patients underwent polygraphy recordings. The median 
ODI
4
 had decreased from 26.5 (range 4–82) to 8.5 (0–60) (p < 0.01), a mean 
reduction of 52%. Sixty-five per cent of patients satisfied the success criteria. 
One third were objectively categorised as non-snorers. The median BMI was un-
changed. The questionnaires were answered by 32 of 37 patients; 88% reported 
improved or cured EDS and 78% were satisfied. The median ESS score 15 years 
after UPPP surgery was 6 (0–19). Pharyngeal disturbance ratings were low. The 
standardised mortality rate did not differ from that of the general Swedish po-
pulation.
Paper 3 was a prospective RCT called Sleep apnoea Karolinska UPPP (SKUP3), 
with two parallel arms and stratification by Friedman stage and BMI. Sixty-five 
consecutively included patients with moderate to severe OSAS, BMI < 36 kg/
m2, ESS ≥ 8, Friedman stage I or II. Sixty-five patients were randomised to in-
tervention (UPPP) or control (expectancy and UPPP after a delay of six months). 
The mean AHI measured by polysomnography in the intervention group had 
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significantly decreased by 60%, from 53.3 (sd 19.7) to 21.1 (16.7). In the con-
trol group, the mean AHI decreased by 11%, from 52.6 (21.7) to 46.8 (22.8), a 
significant difference between the groups. The mean time in the supine position 
and BMI were unchanged in both groups. Subgroup analyses of Friedman stage, 
BMI group and tonsil size all showed significant reductions of AHI in the inter-
vention group, compared to controls. There were no severe complications after 
surgery.
In Paper 4 the same SKUP3 subjects were evaluated concerning changes in the 
ESS and the quality of life, as well as in vigilance tests. The mean ESS in the 
intervention group decreased significantly from 12.5 (sd 3.2) to 6.8 (3.9), but 
there was a non-significant change in the control group. Significant differences 
between groups in favour of UPPP involved changes in the ESS, several SF-36 
domains (general health, vitality and social functioning), as well as in sleep la-
tency. Changes in the ESS correlated significantly with changes in vitality, social 
functioning and sleep latency, as well as with changes in the AHI, nadir O
2
 and 
the arousal index. 
In summary, tracheostomy may constitute an alternative treatment in obese pa-
tients with severe OSAS. The improvements in nocturnal respiration and dayti-
me sleepiness after UPPP appeared to remain stable after 15 years. UPPP may 
also have a protective role against mortality. The SKUP3 showed that modified 
UPPP significantly improved respiratory parameters, daytime sleepiness and the 
quality of life, compared to controls. Since upper airway surgery appears to be 
effective and safe, it should be offered to selected OSAS patients.
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INTRODUCTION
Summarised introduction to the present studies 
Obstructive sleep apnoea syndrome (OSAS) is a common disease, with a preva-
lence of 2% in females and 4% in males.1 The syndrome is defined by repetitive 
upper airway obstruction during sleep, which reduces the airflow during inspira-
tion, despite a continued respiratory effort. These obstructive hypopnoeas and/
or apnoeas result in fragmented sleep, frequent awakenings, and even oxygen 
desaturation. The quality of life is affected with an increased risk of poor sleep 
quality, excessive daytime sleepiness (EDS) and an increased risk for traffic ac-
cidents.2 This also leads to an augmented risk of developing cardiovascular di-
seases, stroke and death.3-5 
Patients with OSAS can be treated in several alternative ways: especially conti-
nuous positive airway pressure (CPAP) or a mandibular retaining device (MRD), 
and more seldom surgically; mainly uvulopalatopharyngoplasty (UPPP) or, in 
very severe cases, tracheostomy. The treatment of OSAS in adults is a challenge 
since the compliance with non-surgical treatments like CPAP device and MRD 
is approximately 56–68% after 4–5 years,6, 7 and therefore many patients risk re-
maining untreated. These patients could be offered surgery. Although UPPP was 
the predominant treatment for OSAS before CPAP was generally available, there 
is a lack of randomised controlled trials (RCTs). Furthermore, the efficacy of 
UPPP in OSAS treatment has been questioned, also in the long-term perspective. 
The Swedish Council on Technology Assessment in Health Care (SBU) report 
on OSAS from 20078 and the Cochrane report on OSAS surgery from 20059 
draw the conclusion that more studies on surgical treatment for OSAS need to 
be done. As for all surgical interventions, the possibility of making blinded stu-
dies is difficult and therefore the evidence for efficacy is limited. However, the 
reports from SBU and Cochrane have been a wake-up call for the Oto-Rhino-
Laryngology (ORL)-specialty and an inspiration for this thesis, as they have 
called attention to the insufficient scientific evidence concerning the efficacy of 
upper airway surgery in OSAS treatment. Furthermore, they have highlighted 
the difficulties connected with evaluating efficacy, side-effects and complication 
rates when different outcomes, surgical techniques and multilevel procedures 
have been used. 
The overall aim of this thesis was to evaluate upper airway surgery, with short 
and long-term follow-up times in OSAS patients, using descriptive, observatio-
nal and randomised controlled studies.
16
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Clinical background of OSAS
SDB, OSA, OSAS and OHS 
Sleep disordered breathing (SDB) includes a wide range of sleep-related brea-
thing disorders, snoring and mouth breathing, OSAS.10, 11 The mechanism is cha-
racterised by sleep-induced muscle relaxation, leading to partial or complete 
upper airway obstruction despite continuous or increased breathing efforts. The 
sleep pattern is fragmented, mainly due to the arousals as a result of the obstruc-
tive breathing. As a consequence, symptoms of daytime sleepiness often follow, 
and the condition is then defined as OSAS.Obstructive sleep apnoea (OSA) is 
the laboratory diagnosis after sleep recording without paying attention to the 
patients’ daytime symptoms.The narrow pharyngeal airway predisposes to sno-
ring, increased respiratory resistance and obstructive episodes of sleep apnoea, 
but OSA and OSAS are not only to be regarded as a local abnormality of the 
respiratory track, but also more of a systemic illness,12 discussed further below. 
The term SDB also includes central sleep apnoea syndromes, characterised by 
disturbances in the respiratory effort, without obstructive mechanisms.  See fi-
gures 1 and 2 for a sleep registration in a healthy person and a person with OSA.
Obesity hypoventilation syndrome (OHS) has clinical features such as obesity, 
daytime hypoventilation and SDB in the absence of an alternative neuromuscu-
lar, mechanical or metabolic explanation for hypoventilation.13 The syndrome 
was initially termed the Pickwickian syndrome.14 Studies have reported a pre-
valence of OHS between 10 and 20% in obese patients with OSA and the pre-
valence of OHS is higher in the subgroup of patients with OSA combined with 
extreme obesity.13 The mechanisms that lead to hypoventilation and hypercapnia 
in OHS are most likely multifactorial and include the presence of SDB and a 
blunted central response to hypercapnia and hypoxia.13 Most patients with OHS 
have underlying upper airway obstruction and a symptomatology with daytime 
sleepiness similar to that reported in OSAS.15  
Prevalence 
The prevalence of OSAS varies across different definitions and different study 
populations, but it is assumed to be 4% in males and 2% in females also in Swe-
den, which is similar to the figures in the USA during the 1990s.1 The prevalence 
of OSA without daytime symptoms was 17–26% in males and 9–28 % in fema-
les in previous studies from abroad.1, 16, 17 Surprisingly, the prevalence of OSA 
in Swedish females from Uppsala County was shown to be very high (50%) in 
a recent epidemiological study.18 Obesity, older age and hypertension were risk 
factors. The prevalence of OSA, as well as the severity of the disease according 
to the apnoea-hypopnoea index (AHI), seems to increase with age in both males 
17
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Figure 2. Polygraphy in a patient with obstructive sleep apnoea. Note the 
repetitive obstructive apneoas causing severe oxygen desaturations.
Figure 1. Normal polygraphy.
18
Nanna Browaldh, 2013
and females, although males have a higher prevalence of OSA.1, 16 The gender 
differences for the prevalence rates are further discussed under pathophysiology 
and risk factors below.  
Incidence and progression
The incidence of OSA is also described as being higher in males than in females. 
The Sleep Heart Health Study concluded that the incidence for at least moderate 
OSA with AHI > 15 was 11% in males and 5% in females over a period of 5 
years.19  Several studies concluded that weight gain was a critical factor in the 
progression of the disease.19, 20 Additional factors for the progression of OSA in 
adults may be pharyngeal neuromuscular impairment due to mechanical trauma 
and related inflammation in the pharyngeal upper airways as a consequence of 
the vibration and stretching related to snoring.21, 22 
Pathophysiology and risk factors
During sleep the muscular tone naturally decreases. All mechanisms or factors 
that have the capability to aggravate the increased upper airway lumen resistance 
during sleep add to the risk of airway collapse. The main risk factors for OSA are 
decreased patency of the upper airway for obstructive reasons, obesity and male 
gender.1, 23, 24 Further important risk factors for OSA are advanced age, a family 
history of OSA, alcohol, smoking25 and reflux.26 
Age 
The prevalence of OSA increases with age.16-18 Among several different age-
dependent factors, Malhotra et al.27 found an age-dependent decrease in the re-
sponse to negative pressure, an increased deposition of parapharyngeal fat, a 
lengthening of the soft palate and change of the shape of the bones surrounding 
the pharynx. All these findings could predispose to an upper airway collapse 
during sleep. 
Gender
A higher prevalence of OSAS with a ratio of 2 to 3:1 for males compared to 
females in general population has been reported,28 but the differences between 
the genders seem to decrease with age.29 Many different reasons for the higher 
prevalence of OSAS in males have been discussed. White et al. reported that 
despite the larger upper airway dimensions in males, the breathing resistance is 
relatively higher.30 Furthermore, Schwab et al. suggest that gender differences 
may be dependent on a higher resting tone of pharyngeal dilatators in females, 
different fat distributions and other anatomical factors.31 There are also studies 
that suggest that female hormones could be protective.29, 32 
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Other possible explanations for the higher clinical male ratio may be differences 
in occupational, environmental and health risk factors between genders. In sleep 
clinic populations, the male predominance is higher than in general population-
based samples, as reported by Lindberg et al.33 Hypothetically, females could 
present with different symptoms of OSA from males, or the symptoms are mis-
diagnosed with other illnesses, for example, depression. Although in a study by 
Young et al., significant differences between reported symptoms in males and 
females were not seen.34 
Upper airway anatomy in OSAS patients
Snoring and apnoeas are signs of upper airway obstruction. The main obstructive 
sites in OSA are retropalatal, retroglossal and hypopharyngeal or a combination 
of several sites. The negative intraluminal pressure generated during inspira-
tion and the Bernoulli principle result in a suction force, especially around these 
main narrow anatomical sites. All anatomical factors that contribute to the upper 
airway narrowing during sleep may increase the risk of collapse. Macroglossia, 
excessive mucosa in the posterior pharyngeal walls, large tonsils, and elongation 
of the uvulopalatal region, nasal obstruction and deformity or disproportion of 
the facial skeleton are all possible structural upper airway narrowing factors. 
Among OSA patients, palatal tonsil hypertrophy amounts to only about 6%, as 
reported in one study by Dahlqvist et al.35 The study comprised of 801 snoring 
males and females referred for evaluation of sleep apnoea. It showed that large 
tonsils, a high tongue and a wide uvula in males and large tonsils and mandi-
bular retrognathia in females were found to be independent factors associated 
with an AHI > 15. The authors concluded that these anatomical findings were 
unreliable for predicting OSA among snorers being investigated for suspected 
sleep apnoea. Another study on the anatomical associations connected with OSA 
investigated 420 patients who had been referred to a sleep clinic because of ana-
tomical abnormalities of the oropharynx.36 After adjusting for the body mass in-
dex (BMI) and neck circumference, only enlarged tonsils and lateral narrowing 
of the pharyngeal walls were found to be significant, but not an enlarged uvula, 
a low-lying soft palate, retrognathia or overbite. Furthermore, a study showed 
that significant predictors of OSA in non-obese females were a low soft palate, 
retrognathia and a uvula touching the posterior wall in the supine position.37 
Overweight
Overweight is one of the main single risk factors for SDB.1 Forty per cent of 
obese males have OSAS and 70% of OSAS patients are obese.38 There are also 
studies that report that changes in AHI are related to changes in weight: a 10% 
weight gain in patients with SDB increases AHI by 32% and, conversely, that 
a 10% weight loss is associated with a 26% decrease in the AHI.39 Ciscar et al. 
noted in their study that OSAS patients have more fat in the lateral pharyngeal 
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walls than non-OSAS patients with similar BMIs.40 Patients with extreme obe-
sity also risk developing OHS. 
There are discussions as to whether OSAS is an anatomical disorder or not.41,42 
Obesity may affect the anatomy, including the upper airway anatomy, but it 
could also play a role through its metabolic activity, just as in the metabolic syn-
drome. In the article by Vgontzas et al.,12 the authors concluded that obesity may 
contribute to the pathogenesis of sleep apnoea, sleepiness and the associated 
cardiovascular co-morbidities. 
Heredity
Heredity has also been suggested to predispose to OSAS. In a study of 2350 
OSAS patients from Iceland, the risk ratio for a first-degree relative of a patient 
with OSAS was 2.0.43 An epidemiological study from our group showed an in-
creased risk in adult siblings of having a hospital diagnosis of OSAS (standar-
dised incidence ratio, SIR, 3.3).44 Apart from heredity, the result may be influ-
enced by increased awareness in OSAS families. Another study from our group 
concluded that there was familial clustering of SDB among parents and their 
children.45
 
Smoking, alcohol and reflux 
Mechanisms contributing to the airway collapse are inflammation and oedema of 
the pharyngeal mucosa caused by smoking, alcohol consumption or gastroesop-
hageal reflux.25, 26, 46, 47 
Several studies have reported that current smoking is associated with an in-
creased risk of OSA. The Wisconsin Sleep Cohort Study showed a 4.4 times in-
creased risk of moderate to severe OSA in smokers compared to non-smokers.46 
Alcohol decreases muscle tone and increase the AHI and hypoxaemia in other-
wise normal men.48 The prevalence of alcohol abuse did not differ from that of 
approximately 10% in the general population in Sweden according to a study 
from our group.49 
Snore-induced mechanical damage and local neuropathy
To prevent the upper airway from collapse during sleep, several nerves and mus-
cles are activated. The vibrations from snoring may cause local nerve lesions 
that gradually lead to a collapse of the pharyngeal upper airway. Furthermore, 
several studies from our group indicate an impaired pharynx dilatation reflex 
owing to nerve lesions, abnormal pharyngeal muscles and inflammation.22, 50 The 
degree of muscular,22 as well as sensory neuropathy51 in the upper airway cor-
related with the degree of OSA.
21
Upper airway surgery in obstructive sleep apnoea.......
Supine sleep
In general, the frequency and severity of apnoea increase in the supine position 
owing to the force of gravity that predisposes the tongue and mandible to fal-
ling backwards. Fifty-six per cent of patients with OSA have position-dependent 
OSA (defined as a difference of 50% or more in AHI for supine and non-supine 
positions), as reported by Oksenberg et al.52 Furthermore, young, thin patients 
with mild to moderate OSA were more likely to have position-dependent OSA 
than older, obese patients with severe OSA. In a recently published study by 
Sunnergren et al., it was found that more than 50% of the studied population of 
265 subjects had position-dependent OSA, suggesting that variations in supine 
time between nights can cause large AHI variations.53 This can influence the 
night-to-night variability described under Diagnosis of OSAS below. 
Morbitidy and mortality
OSAS is a risk factor for cardiovascular disease, including hypertension and 
stroke, but also for the metabolic syndrome, diabetes, gastro-oesophageal reflux 
and pharyngeal disturbances.3, 26, 39, 54-56 Furthermore, the risk for traffic accidents 
is also increased in OSAS.2 The evidence is particularly well-documented and 
strong for cardiovascular disease, three major mechanisms having been descri-
bed.57 Primarily, the arousals following apneoas and hypopnoeas lead to sym-
pathetic nervous system over-activity and increased levels of catecholamines. 
Secondly, the balance of partial pressures of blood oxygen and carbon dioxide 
induced by the obstructive breathing events is disturbed. Finally, there is an 
increase in the negative intrathoracic pressure caused by the continuous brea-
thing against the occluded airway. The pathogenesis of cardiovascular disease in 
OSAS is probably multifactorial, thus it also includes endothelial dysfunction, 
abnormal coagulation, increased inflammation activity and metabolic dysregula-
tion.58  
Hypertension
The prevalence of OSA is about 30–83% among patients with hypertension.57 
In the Wisconsin Sleep Cohort Study, Peppard et al. reported a dose-response 
relationship between the severity of SDB at baseline and hypertension at the 
four-year follow-up. The odds ratio for development of hypertension in patients 
with an AHI >15 was 2.9, compared to patients with AHI = 0, independently of 
known confounding factors.56 In patients with resistant hypertension, OSA is 
particularly common.59 
Cardiovascular disease and stroke
A large observational study by Marin et al. showed that the incidence of fa-
tal and non-fatal cardiovascular events (stroke, myocardial infarction and acute 
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coronary insufficiency requiring an invasive intervention) in untreated patients 
with severe OSA was significantly three times higher than in a matched control 
group from the general population.3 Furthermore, CPAP treatment significantly 
reduced the cardiovascular risk. 
The prevalence of OSA is reported to be 11–37% in patients with congestive 
heart failure and 43–72% in patients with stroke,60 and stroke can both precede 
and follow the stroke event.61 The Wisconsin Sleep Cohort found that an AHI 
> 20 led to an odds ratio of 4.3 for the risk of stroke, compared to an AHI < 5 
during the 4-year follow-up.62  
Diabetes and the metabolic syndrome
Punjabi et al. reported that OSA is a risk factor for developing glucose intole-
rance, insulin resistance and type 2 diabetes.54 In the Swedish community-based 
cohort of 141 males without diabetes at baseline studied by Lindberg et al., it 
was found that an ODI > 5 at baseline was a predictor of developing diabetes, 
with an odds ratio of 4.4 after adjustment for known confounders.63 Both the 
prevalence and incidence of diabetes increased with increased levels of SDB at 
baseline, but they may be confounded by obesity.64 
Gastro-oesophageal reflux and pharyngeal disturbances
Gastro-oesophageal reflux has been reported to be higher in OSAS patients than 
in the normal population.65 Different mechanisms may be repeated increases in 
negative intrathoracic pressure or transient lower oesophageal sphincter relaxa-
tion.65 A longitudinal population-based study by Emilsson et al., showed that 
persistent symptoms of nocturnal gastro-oesophageal reflux significantly contri-
buted to the development of respiratory symptoms (odds ratio, 3.0).26 Treatment 
with proton pump inhibitors has also significantly decreased the level of AHI in 
OSA patients with gastro-oesophageal reflux, as shown by Friedman et al.47 
Our group has previously evaluated the results from UPPP patients both pre- and 
postoperatively55 and demonstrated no increased rating of pharyngeal discom-
fort postoperatively, with a median value of 5. However, in a non-snoring age-, 
BMI- and gender- matched control group, the median value was only 1. This dif-
ference indicates a certain amount of discomfort already before surgery among 
the OSAS patients,55 possibly owing to the vibrational trauma and obstructive 
tension of the pharyngeal tissue.66 
Traffic accidents
There is a 3 to 7-fold increased risk for traffic accidents in OSAS patients, com-
pared to normal subjects, already at AHI > 5.2 Although sleepiness is a common 
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risk for traffic accidents, several studies found that the association between OSA 
and traffic accidents is not dependent on sleepiness.2, 8 In a study by Haraldsson 
et al., the risk for single-car accidents returned to normal after treatment with 
UPPP.67 
Mortality
OSAS is associated with an increased mortality rate. The Wisconsin Sleep Co-
hort Study with a follow-up period of 18 years showed an association between 
both all-cause mortality (hazard ratio, HR, 3.0) and cardiovascular-related mor-
tality (HR, 5.2) in OSA patients after adjusting for potential confounders.4 Simi-
lar results were shown in a study by Marshall et al., which reported an increased 
risk of all-cause mortality (HR, 6.24) in patients with moderate to severe OSA 
in a 14-year follow-up.5 Marin et al. demonstrated in a 10-year follow-up that 
in patients with an AHI > 30, the increased risk for cardiovascular death was 
2.87.3 Furthermore, simple snorers and OSAS patients under CPAP treatment 
showed similar morbidity and mortality rates to those in the general population. 
A Swedish population-based study showed that there was an increased mortality 
rate of 2.7 in men < 60 years of age with both snoring and EDS compared to 
men without snoring or EDS, adjusted for age.68 There are also studies reporting 
declining mortality rates in elderly men with moderate to severe sleep apnoea69 
and that older patients with mild and moderate OSA had a lower mortality rate 
than the matched population.70   
Symptoms of OSAS
Many different symptoms are connected with OSAS, and in the following seg-
ments, EDS and the quality of life (QoL) will be discussed. Many different cau-
sative factors could have an impact on EDS and QoL; for example, age, phy-
siological and psychological diseases, depression, family situation and sleeping 
habits. Also depression, obesity and the metabolic syndrome have been sug-
gested to be major factors associated with EDS.71 A clinical examination inclu-
ding various questionnaires is often used to exclude other reasons for EDS. The 
answers to the question concerning which factors may cause the symptoms in 
OSAS are probably multidimensional. 
Daytime sleepiness
The cardinal symptoms of OSAS are EDS and/or fatigue, which may affect daily 
activities and QoL. Patients who are referred to a sleep clinic for evaluation of 
OSAS often describe symptoms of EDS, a lack of energy and/or a sense of un-
refreshing sleep. The Wisconsin Sleep Cohort Study reported that 23% of fema-
les and 16% of males with an AHI > 5 reported sleepiness at least two days a 
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week. In subjects without SDB, the corresponding figures were 10% and 3%, 
respectively.1 The occurrence of EDS in patients with OSAS has been ascribed 
to nocturnal hypoxaemia, sleep fragmentation, or both.72 The Sleep Heart Health 
Study reported significant associations between EDS (measured on the Epworth 
sleepiness scale, ESS), snoring and the respiratory disturbance index (RDI), re-
spectively.73, 74 Furthermore, Goncalves et al. showed that ESS scores correlated 
significantly with the arousal index and the AHI and negatively with the nadir of 
oxygen saturation.75 
There is, however, often a discrepancy between objective signs and symptoms 
related to OSAS. Weaver et al. investigated whether polysomnography indexes 
were associated with EDS (measured with the ESS) and QoL (measured with 
the Short-form 36, SF-36, and the Functional Outcomes of Sleep Questionn-
aire, FOSQ) in mild to moderate OSAS patients.76 The patients were randomised 
to either surgical treatment with radiofrequency tongue and palate reduction or 
sham surgery. The authors concluded that there was a poor correlation between 
polysomnography (PSG) indexes and associated sleepiness, QoL or reaction 
time, measured both at baseline and as changes in the outcome. Roure et al. 
investigated patients with an AHI > 5 (measured with PSG) with (ESS > 10) or 
without (ESS < 10) symptoms of EDS.72 There were differences between groups 
regarding several parameters. For example, total sleep time, sleep efficiency, the 
AHI and the arousal index were all significantly higher and the nadir of oxygen 
saturation was significantly lower in the group with EDS symptoms. The authors 
concluded that although patients with EDS showed worse respiratory and sleep 
disturbances, sleep apnoea and sleep disruption are not the primary determinants 
of EDS in all patients. Furthermore, Vgontzas el al.,12 suggested that inflamma-
tory cytokines are mediators of EDS and that sleep apnoea and sleepiness may 
be a manifestation of the metabolic syndrome. 
Quality of Life
Both the Wisconsin Sleep Cohort Study and the Sleep Heart Health Study have 
shown associations between the SF-36 and the degree of OSA, and the results 
from the SF-36 were comparable to those for patients with other chronic di-
seases.77, 78 Patients with OSA also had an impaired QoL compared to an age- and 
gender-matched control group.79 The PSG parameter arousal index is also found 
to correlate significantly with several subscales of the SF-36.75 The SBU-report 
concluded that there was an improvement in the vitality domain of the SF-36 
after CPAP treatment, but only a few studies were available and the scientific 
evidence was insufficient.8 
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Diagnosis of OSAS
The evaluation of OSAS is multidimensional. The individual view concerning 
the quality of sleep is highly subjective and it is often described as undisturbed 
and restorative. Based on the laboratory and clinical perspective, it can be mea-
sured with polygraphic or polysomnographic recordings, and the evaluation of 
EDS will also be described in more detail below. There are disadvantages with 
all types of tests and therefore it is important to keep in mind that questionnaire 
are sensitive to recall bias, motivation, degree of education, and fatigue,80 as well 
as personality. Objective tests are often more expensive and complicated and 
have poor availability. Furthermore, correlations between different evaluations 
of OSAS are not necessarily concordant, and this also applies to the perspective 
of daily life. The definitions of both OSA and OSAS have changed over the 
years and a new version of the guidelines for classifications appeared in 2013. In 
the following, the guidelines for OSAS from 199910 (used in this thesis) and for 
OSA, adult from 200511 will be described in detail (Box 1 and 2). Furthermore, 
the revised criteria for scoring hypopnoeas from 2007 will be described.81
Evaluation of sleep
The diagnostic criteria for OSAS according to the American Academy of Sleep 
Medicine (AASM) 199910 are presented in box 1 below.
Box 1. Definition of obstructive sleep apnoea syndrome suggested by American Aca-
demy of Sleep Medicine in 1999 (AASM 1999)      
        
The individual must fulfill criterion A or B, as well as criterion C.
A.  Excessive daytime sleepiness that is not better explained by other factors. 
        
B.  Two or more of the following that are not better explained by other factors:  
– choking or gasping during sleep
 – recurrent awakenings from sleep     
 – unrefreshing sleep      
 – daytime fatigue       
 – impaired concentration.
      
C.  Overnight monitoring demonstrating five or more obstructive breathing  
events per hour during sleep. These events may include any combination  
of obstructive apnoeas/hypopnoeas or respiratory effort-related arousals.
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The severity of OSAS has two components: severity of daytime sleepiness and 
severity of laboratory sleep recording according to the level of obstructive brea-
thing events:
 1. Mild: 5–14.9 events/hour
 2. Moderate: 15–29.9 events/hour
 3. Severe: > 30 events/hour
The rating of severity for the syndrome should be based on the most severe 
component.
Box 2. International Classification of Sleep Disorders. Diagnostic criteria for  
obstructive sleep apnoea 2005 (AASM 2005)     
        
 A, B and D or C and D satisfy the criteria:     
         
 A.  At least one of the following applies:    
i)  The patient complains of unintentional sleep episodes during 
wakefulness, daytime sleepiness, unrefreshing sleep, fatigue or 
insomnia,
ii)   The patient wakes with breath holding, gasping, or choking, 
iii)  The bed partner reports loud snoring, breathing interruptions, or 
both during the patient’s sleep.     
   
 B.  Polysomnographic recordings shows the following: 
i)   Five or more scoreable respiratory events (i.e., apnoeas,  
hypopnoeas, or respiratory effort related arousals, RERAs) per 
hour of sleep.
ii)  Evidence of respiratory effort during all or a portion of each  
respiratory event (in the case of a RERA, this is best seen with 
the use of esophageal manometry).    
 
 OR      
        
 C.  Polysomnographic recording shows the following: 
i)  Fifteeen or more scoreable respiratory events (i.e., apnoeas,  
hypopnoeas, or RERAs) per hour of sleep. 
ii)  Evidence of a respiratory effort during all or a portion of each 
respiratory event (in the case of a RERA, this is best seen with 
the use of esophageal manometry).     
 
D.  The disorder is not better explained by another current sleep disorder,  
medical or neurological disorder, medication use, or substance use 
disorder. 
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Definition of parameters according to AASM 200781: 
The AHI is the total number of ≥ 90% decreases in airflow compared to baseline 
(apnoea) and partial obstructions (hypopnoea) of breathing occurring per hour 
of sleep. The event must last for at least 10 seconds and is associated with a 
decrease in oxygenation of the blood. In general, the AHI is used to classify the 
severity of disease. 
Hypopnoea  Criteria A (used at polygraphy, PG, in Paper 2)
 • ≥ 30% flow limitation at the nasal cannula and
 • ≥ 4% desaturation or an arousal
Hypopnoea  Criteria B (used at PSG in Papers 3 and 4)
 • ≥ 50% flow limitation at the nasal cannula and
 • ≥ 3% desaturation or an arousal
Respiratory effort-related arousal (RERA) (used at PSG in Papers 3 and 4)
 • <  30%  flow limitation at the nasal cannula and
 • arousal
Respiratory disturbance index (RDI): AHI plus RERA index (events per sleep 
hour).
Oxygen desaturation index (ODI) is the average number of oxygen desaturations 
per hour of sleep. The desaturations can be measured at different levels compa-
red to baseline. ODI 4% (ODI
4
) is used in Papers 1 and 2, and ODI 3% (ODI
3
) 
in Papers 3 and 4. 
Diagnostic levels
A nocturnal sleep investigation using PSG is the golden standard for determining 
respiratory events. This recording includes an electroencephalogram (EEG), an 
electro-oculogram (EOG), an electromyogram (EMG), an electrocardiogram 
(ECG), airflow, respiratory effort, oxygen saturation and body position. The 
PSG can be done in a sleep laboratory (level 1), as in Papers 3 and 4, or at home 
when the heart rate might substitute for ECG (level 2).82  
A full PSG measures both sleep and breathing parameters. The advantages of 
PSG compared to PG are mainly that PSG measures the arousals caused by ob-
structive events and the exact time of sleep, which enables a more exact calcula-
tion of the respiratory and sleep events. PSG is resource-demanding and costly 
and therefore the simplified ambulant PG (level 3) is widely used. The device 
should record ventilation (at least two channels of respiratory effort or airflow 
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and one respiratory effort channel). ECG or heart rate and oxygen saturation 
should also be recorded.82 The PG used in Papers 1 and 2 included nasal respi-
ratory airflow, respiratory effort belts (thorax and abdomen), ECG and oxygen 
desaturation. The same equipment was used in Paper 2 after 15 years as in the 
previous follow-ups after 6 months and 2 and 4 years. See figures 3 and 4 for 
examples of PG and PSG.
The disadvantage with PG is that the total sleep time risk can be estimated to 
be longer than the actual true sleep time. This means there is a risk of diluting 
the AHI, which will actually be lower than the true AHI. Furthermore, since PG 
lacks EEG, EOG and EMG, arousals and sleep stages cannot be measured. This 
risk of a lower rate of both hypopnoeas and RERA events and sleep fragmenta-
tion is not truly evaluated. To enhance the estimation of sleep time in PG, the 
subjects in a study by Santos-Silva et al. were told to record when they went to 
sleep, wake-up time and wake-up periods of more than 15 minutes. This study 
showed strong correlations between AHI recorded with both PG and PSG.83 
Additionally, a study by Franklin and Svanborg reported that the correlation 
between PSG-recorded sleep time and subjective sleep time is adequate, even 
though the individual differences are large.84 In a clinical study from our group, 
patients with ’normal’ PGs and symptoms of tiredness and/or sleepiness, as well 
as snoring, underwent PSG, and 90% had at least a mild degree of OSAS.85 In 
the clinical situation, it is therefore important to offer PSG to patients with EDS 
and snoring when PG is ’normal’, as PG cannot exclude OSAS. See figure 5 for 
an example of PSG recording.
Figure 3. Schematic figure of a polygraphy 
device that records oro-nasal airflow, thora-
cic and abdominal belts to register breathing 
efforts, pulse oximetry, and measurements 
of pulse frequency, snoring sound and body 
position. 
Figure 4. Photography of a polysomnography 
recording with registration of EEG, EOG, ECG, 
submental EMG, oro-nasal airflow, with simul-
taneous registration of breathing efforts with 
thoracic and abdominal belts, pulse oximetry, and 
measurements of pulse frequency, snoring sound 
and body position. 
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Night-to-night variability and sleeping position
The night-to-night variability between recordings may vary for different re-
asons: for example, sleeping position, intake of alcohol, but also getting used 
to the equipment. One way to enhance the diagnostic precision is to perform re-
cordings on at least two consecutive nights. Bittencourt et al. showed in a study 
with 20 subjects that there was no significant difference between the mean AHI 
on four recorded nights, but a substantial individual variability, and 50% of the 
subjects showed a change in the degree of OSA severity from the first night to 
the following nights.86 Conversely, a review published by the SBU concluded 
that the AHI shows good agreement between two nights of PSG.8 Also Mendel-
son et al. found that one night of PSG should generally be sufficient and, in 50 
patients with suspected OSA, the correlation of the AHI between nights was high 
(r = 0.86).87 
Figure 5. Polysomnographic recording of a patient with obstructive sleep apnoea. An 
obstructive apnoea is marked with a rectangle, followed by an arousal shown in EMG of 
the chin and EEG channels, arrows.
Subjective evaluation of daytime sleepiness
EDS can be evaluated in several different ways, including both subjective and 
objective measurements. ESS is the most frequently used subjective sleepiness 
assessment test for OSAS.88 The version of the ESS used was translated into 
Swedish upon request by the Swedish Society for Sleep Research and Sleep 
Medicine. It has been back-translated into English and approved by M.W. Johns. 
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The ESS is a self-administered eight-item questionnaire pertaining to the pro-
pensity to fall asleep in different situations in daily life. The questionnaire eva-
luates the situation during the past two weeks and the items are presented in 
scales of 0–24.88 The interpretation of the scale results varies among studies, but 
in some studies an ESS score of 8–10 is called mild sleepiness, 11–15 moderate 
sleepiness, 16–20 severe sleepiness and 21–24 excessive sleepiness.89  
The advantages of the ESS are that it is designed to reflect the patient’s subjec-
tive symptoms, and it is inexpensive and easy to administer. It is useful intra-
individually when evaluating the effect of treatment on EDS. However, a study 
by Nguyen et al. found that when the ESS questionnaire was administered twice 
with a few months’ interval, 23% had a difference of at least 5 scale points.90 
Results from the Sleep Heart Health Study showed that ESS ratings correlated 
positively with the AHI, but patients with the worst apnoeas had a mean ESS 
score of 9, compared to normal subjects with a mean score of 7.74 Yaremchuk 
et al. studied the relationship of the ESS and the AHI and found that the only 
significant predictor of the change in the ESS was the initial ESS score and that 
the AHI was not related to the change in the ESS.91 Another weakness of the ESS 
is the risk of recall bias. Furthermore, a small, but reproducible differential item 
functioning (a subject’s response to the item is affected by other aspects than that 
which the test is intended to assess) for age has been described.92 
Another questionnaire for evaluating EDS is the Basic Nordic Sleep Ques-
tionnaire (BNSQ), which consists of 21 main questions about sleep, stressing 
how many occasions per week something has occurred during the past three 
months.93 The BNSQ was developed to create a standardised questionnaire for 
Nordic countries. The Karolinska Sleepiness Scale94 and the FOSQ95 are also 
frequently used in sleep studies. 
Objective evaluation of daytime sleepiness
The objective tests of EDS are often time- and facility-demanding and are 
therefore difficult to use in clinical practice. The Multiple Sleep Latency Test 
(MSLT)96 measures the ability to fall asleep and consists of a 20-minute test, 
which is repeated four to five times with two- hour intervals. The Maintenance of 
Wakefulness Test (MWT)97 measures the ability to stay awake during 40 minutes 
and is repeated four times a day. Both tests record sleep latency with EEG, EOG 
and EMG. 
The Oxford sleep resistance (OSLER) test is an objective sleepiness test suita-
ble for OSAS patients.98 It has been shown to distinguish normal sleep subjects 
from OSAS patients as well as the traditional test, the MWT. The OSLER test 
is performed in a dark room, isolated from external noise. The original test is 
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performed 4 x 40 minutes during one day and the patient is asked to remain 
awake and press a switch in response to a small illuminated light, lit every three 
seconds. When the patient fails to respond for 21 seconds, the test is ended, and 
it is understood that the patient is asleep. The standard analytical purpose of the 
OSLER test is to determine sleep latency, measured as the delay before seven 
consecutive flashes without a response. The test is less expensive and easier to 
use, although it does not involve EEG. A modified OSLER test was used in Pa-
per 4. The associations between objective and subjective measurements of EDS 
are not always coherent.99 
Evaluation of Quality of Life
The health survey SF-36 covers 8 domains of health-related quality of life mea-
surements (HRQoL) for evaluation of the last four weeks. The domains are: 
physical functioning (PF), role physical (RP), bodily pain (BP), general health 
(GH), vitality (VT), social functioning (SF), role emotional (RE) and mental 
health (MH). Scores from each subscale range from 0 to 100, and a higher score 
indicates a better HRQoL.100 The SF-36 also includes the Mental Component 
Summary (MCS) and the Physical Component Summary (PCS). These summary 
scores replicate the results from the eight domains of the SF-36. The Swedish 
version of the SF-36 has been translated from English and validated for the Swe-
dish population.101, 102 The SF-36 questionnaire was used in Paper 4. 
Determination of the level of upper airway obstruction
Friedman stage
In 2002 Friedman et al. found in a non-randomized study that their staging sys-
tem (Figure 6) based on palate position, tonsil size and the BMI predicted a 
positive treatment effect of UPPP.103, 104 The authors demonstrated a success rate 
(defined as RDI reduced by at least 50% and a postoperative RDI of 20 or less) 
of as high as 80% for patients with Friedman stage I and 38% for Friedman 
stage II. Furthermore, an additional tongue base reduction was recommended in 
patients with high tongue position. Patients with Friedman stage III, or stage IV 
(BMI > 40), were not recommended to undergo surgery.
Flexible nasal endoscopy of the upper airways
The upper airway anatomy and potential sites of obstruction may be evaluated 
by flexible nasal endoscopy. An additional examination is drug-induced sleep 
endoscopy (DISE), but it is costly and time-consuming. 
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In a recent study by Ravesloot et al., 100 patients eligible for sleep surgery or 
MRD underwent PSG and DISE to investigate the distribution of sites and pat-
terns of obstruction.105 Eighty-three per cent of the patients had palatal obstruc-
tion, 56% had tongue base obstruction, 38% had epiglottis obstruction and 7% 
oropharyngeal obstruction. In 76 patients, a multilevel obstruction was visuali-
sed. The authors concluded that the AHI was significantly higher in patients with 
a multilevel obstruction, and a complete collapse or a tongue base collapse was 
associated with higher AHI values. A tongue base collapse or epiglottal collapse 
was associated with supine-positional OSA. 
In a retrospective study by Koutsourelakis et al., 49 OSA patients underwent 
DISE, upper airway surgery (palatal surgery and/or radiofrequency ablation of 
the tongue base, and/or hyoid suspension), followed by PSG.106 Forty-seven per 
cent of the patients were responders, with a success criterion of a postoperative 
AHI of < 10 events/hour and at least a 50% decrease from the baseline AHI. 
Twenty-two out of 23 (96%) of the successes had a complete (16 of 23) or par-
tial (6 of 23) anterior-posterior collapse of the velum. Complete circumferential 
collapse at the velum or complete anterior-posterior collapses at the tongue base 
were the only independent predictors of upper airway surgery failure. Further 
studies showing that DISE really improves the surgical results are needed before 
DISE will be used in our clinical practice.   
Figure 6. Friedman staging system 2002
Friedman palate 
position I-IV
Tonsil size 1-4
Stage I:  Large tonsils, low tongue
Stage II:  Small tonsils, low tongue
  Large tonsils, high tongue  
Stage III: Small tonsils, high tongue
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Treatment of OSAS
Weight reduction and positional therapy
Weight reduction is a highly effective treatment for OSAS. In an RCT of 63 mo-
derate to severe OSAS patients, the intervention consisted of a very low-energy 
diet for seven weeks.107 In the intervention group, the AHI was reduced by 67% 
compared to baseline, but it was unchanged in the control group. A cohort study 
from our group showed a significant decrease in respiration measured with the 
ODI from 42 to 23, as well as daytime sleepiness measured as an ESS score from 
9 to 5 after a two-year weight reduction programme.108 In addition, significant 
improvements in the SF-36 domains physical functioning and vitality were seen 
in the per protocol analysis. Since many patients have residual OSA, a weight 
reduction programme may be regarded as an adjacent treatment rather than a 
cure.109  
Bariatric surgery has also been shown to be an effective treatment for OSAS and 
has been associated with a decrease in sleep respiratory parameters, as well as 
daytime sleepiness in 100 consecutive obese OSAS patients.110  
Another treatment option is positional therapy, which is aimed at maintaining the 
patient in a preferred position at sleep. There are several different devices, and 
most of them prevent the patient from sleeping in a supine position. In a study 
by Jokic et al.,111 positional treatment was compared to CPAP in 13 patients with 
position-dependent OSA. CPAP was more effective in lowering the AHI, but no 
differences were found between therapies concerning sleep architecture, ESS, 
sleep latency (MWT) and QoL measures. 
CPAP
CPAP treatment for OSA was introduced in 1981 by Sullivan112 and it is the 
golden standard for the treatment of OSA and when fully utilised, it has been 
proven to be very effective for treating upper airway obstruction. The CPAP 
machine delivers a positive airway pressure through a mask to the oropharynx, 
thereby functioning as a splint that keeps the airway open. A meta-analysis of 10 
different studies concluded that the mean AHI was decreased from 32 at baseline 
to 5 during treatment.8 Studies have shown that CPAP therapy is effective for 
reducing all-cause mortality,4 as well as the risk of fatal and non-fatal cardiovas-
cular events.3 A meta-analysis of 18 different studies reported that the mean ESS 
decreased from 12.4 to 8.1 during treatment.8 The largest included study with 
114 patients showed a mean ESS score of 9.2 for the CPAP group, compared to 
10.2 for placebo, and compared to 10.7 at baseline for all the groups together.113 
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In an RCT that compared therapeutic with subtherapeutic CPAP in OSAS 
patients, the ESS was decreased significantly from a median of 15.5 to 7.0 on 
therapeutic CPAP, and from 15.0 to 13.0 on subtherapeutic CPAP.114 Also the 
results from the SF-36 domains RP, RE, MH, VT and vigilance measured by 
the MWT showed significant differences between groups. Furthermore, Pichel 
et al. reported that patients treated with CPAP for 6 months significantly im-
proved the SF-36 vitality dimension, and after 18 months there were additional 
improvements in PF, RP, SF, VT and GH.115 Unfortunately, long-term follow-ups 
are rare, but the median compliance rate is approximately 50–68% after 1–4 
years.6, 116 Furthermore, studies show that approximately 46–83% of patients are 
non-adherent to CPAP treatment for more than 4 hours a night.117 
Mandibular retaining device
MRD is the second most usual treatment for OSAS, especially for patients with 
mild to moderate OSA, who prefer an oral appliance to CPAP or do not respond/
adhere to CPAP.118 The device is generally custom-made by dentists. The SBU 
reported in a meta-analysis of 8 studies that the mean AHI was reduced from 24 
at baseline to 12 during MRD treatment.8 Furthermore, it was reported that in six 
RCTs including patients treated with an active MRD, the ESS decreased from a 
mean of 11.4 to 9.0. Again, the study by Barnes113 is the largest study included 
in this report and showed the same mean ESS value of 9.2 for the MRD as for 
CPAP, compared to 10.2 for placebo. Furthermore, no improvement of objec-
tive sleepiness measured with MWT for CPAP or MRD was seen compared to 
placebo, and the QoL (measured with the SF-36 and the FOSQ) improved to a 
similar degree with both treatments.113 The compliance rate for MRD treatment 
is moderate, i.e., about 56% after 5 years.7 Patients with a mild OSAS are more 
likely to continue treatment than patients with a severe OSAS.119 
Uvulopalatopharyngoplasty and other palatal surgery
Up to now, there is no ultimate treatment option for OSAS patients who do 
not accept or adhere to the non-surgical alternatives. For patients with a clearly 
defined anatomic airway obstruction and prior non-invasive treatment failures, 
surgical treatment may be an option. 
The Cochrane report for OSAS surgery from 20059 and the Nordic meta-analysis 
from 20078 both concluded that there is insufficient evidence for the effective-
ness of surgical intervention for OSA. According to the AASM clinical guide-
lines for OSA in adults, UPPP is not a reliable treatment for reducing the AHI, 
and therefore CPAP and MRDs should be offered to the patient before UPPP.120 
The fact that blinded studies for surgical interventions are challenging may also 
be taken into account. 
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Surgical technique
UPPP was first described by Fujita in 1981,121 the same year as CPAP was in-
troduced. Since UPPP started, it has dominated the surgical treatment of OSAS. 
UPPP includes tonsillectomy and a reduction of the soft palate and uvula, and 
suturing of the tonsillar pillars. Over the years, the surgical techniques have been 
modified to lesser resection of the soft palate and uvula. The removal techniques 
include a conventional scalpel and/or scissors. Laser-assisted procedures for the 
palate are seldom used nowadays in Sweden because of the postoperative pain 
and side-effects. The technique used in Paper 2 and in a previous study by Lund-
kvist et al.122 was a conservative UPPP with cold steel (Figure 9 on page 45), 
meaning a more careful reduction of the soft palate than the technique described 
by Fujita. This technique was initiated at Söder Hospital in Stockholm by As-
sociate Professor Britt Nordlander during the 1980s, and has been used since 
then in our group. However, when the SBU report sounded the alarm about all 
the side-effects after UPPP,8 our research group decided to further modify the 
procedure to be used in Sleep Apnoea Karolinska UPPP (SKUP3), Paper 3 and 4, 
as well as in the clinical routine (Figure 10 on page 45). From 2007, only minor 
resections of the soft palate and uvula have been performed (Figure 7). 
Figure 7. A pharynx before and 7 months after modified UPPP ad modum Karolinska. 
The arrows point at the lumen used for breathing
Respiratory parameters
The definition of success and efficacy for UPPP varies among studies, but the 
most frequently used definition of success is an at least 50% reduction of the 
AHI and/or an AHI ≤ 20. Many authors also present success rates according to 
an AHI ≤ 5 or ≤ 10.123 In a meta-analysis by Caples et al., the ratio of means was 
used. This is a relative measure of effect that describes the extent to which the 
mean postoperative AHI has changed compared to the mean AHI at baseline.124 
The authors showed a 33% reduction of the AHI after UPPP according to 15 
UPPP studies. 
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The patients in Paper 2 were first evaluated at 6 months, 2 and 4 years postopera-
tively, by Larsson et al. regarding daytime sleepiness and sleep apnoea with PG 
recordings.125, 126 They showed significant decreases in the mean ODI
4
 and 50% 
of the patients were regarded as successes (defined as ODI
4
 reduced by at least 
50% and postoperative ODI
4
 < 20). Obesity and severe degrees of OSAS were 
found to be negative predictors.126 Boot et al. followed 58 OSAS patients for an 
average median of 34 months.127 Sixty-three per cent were improved regarding 
snoring and 38% regarding excessive daytime sleepiness. Thirty-eight out of the 
58 included patients (66%) had respiratory sleep recordings at follow-up. Ten 
out of 38 (26%) were classified as successes (ODI
4
 reduced by at least 50% and 
postoperative ODI
4
 < 20). In the study by Lundkvist et al. of 158 patients treated 
with UPPP, the success rate was 64% (defined as ODI
4
 reduced by at least 50% 
and postoperative ODI
4
 < 20).122 The preoperative BMI did not correlate with the 
success rate and no significant difference between the groups with large or small 
tonsils was found. 
Subjective parameters
Yaremchuk et al. reported that the mean ESS score was reduced by 5.6 after up-
per airway surgery including UPPP.91 This  ESS result is similar to those from a 
study by Lundkvist el al., in which the ESS score decreased significantly from 
a median of 12 to 6.122 Eighty-eight per cent of the patients were satisfied after 
UPPP.122 
Walker-Engström et al. investigated the quality of life (measured with the MSE-
P questionnaire) after UPPP and MRD, respectively, in a prospective one-year-
follow up.128 The authors concluded that the mean values for the three dimen-
sions vitality, contentment and sleep improved significantly one year after the 
intervention in both groups. Furthermore, UPPP patients showed a significantly 
higher level of contentment compared to MRD patients, despite the fact that the 
MRD group improved their nocturnal respiration significantly more.129  
Complications in connection with OSAS surgery
Kezirian et al. investigated the complication rate from medical records retro-
spectively for 3130 patients who had undergone UPPP or other surgical proce-
dures for OSAS.130 They demonstrated a 1.5% incidence of serious complica-
tions (mainly respiratory). A high AHI, a high BMI, medical co-morbidity and 
concurrent retrolingual surgical procedures were especially associated with an 
elevated risk of complications. Performance of several surgical procedures si-
multaneously was not recommended.131 The SBU reported a high complication 
rate and concluded that pharyngeal surgery was associated with several adverse 
effects: for example peri- and postoperative bleeding, respiratory compromise, 
and difficulties in swallowing in 28% of the patients after UPPP.8 Franklin et al. 
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investigated the complication rate in Sweden between 1997 and 2004 and con-
cluded that UPPP compared to tonsillectomy did not lead to increased peri-ope-
rative complications.132 In the study by Lundkvist et al., a safety programme was 
used as the clinical routine and 2.5% had serious postoperative complications.122 
Side-effects after pharyngeal surgery in OSAS
Persistent adverse effects have been reported in 14-62% of the patients after 
UPPP, for example difficulties in swallowing, globus sensation, voice chan-
ges and persistent dryness of the throat.8 Levring-Jäghagen et al. investigated 
patients with OSAS using videoradiography and found subclinical pharynge-
al swallowing dysfunction after pharyngeal surgery.133 However, a study from 
our group comprising 58 OSAS patients treated with a conservative, modified 
UPPP showed that the median score for pharyngeal disturbances measured by a 
questionnaire one year after UPPP was unchanged compared to the preoperative 
score. The OSAS patients had significantly higher scores for pharyngeal distur-
bances before surgery than non-snoring controls.55 
Mortality in connection with UPPP: per-operative and long-term
Kezirian et al. reported a per-operative mortality of 0.2% after UPPP or other 
surgical procedures for OSAS.130 Franklin et al. also investigated the mortali-
ty rate in Sweden between 1997 and 2004 and concluded that no mortality at 
all was found after UPPP.132 In a large Swedish study by Lysdahl et al.,134 400 
non-obese heavy snorers were studied. Among these patients, 256 had OSAS. 
The patients had undergone UPPP or laser uvulopalatoplasty (LUPP) and were 
compared with a matched control group of patients who had nasal surgery. The 
authors concluded that there was no increased mortality and that palatal surgery 
may have a protective role. Weaver et al. investigated the mortality in a retro-
spective study of OSAS patients treated with UPPP or CPAP.135 When the data 
were adjusted for age, gender, year of initiation of treatment and co-morbidities, 
the mortality for UPPP was lower than for CPAP.  However, the lack on data on 
the use of CPAP and AHI values are possible explanations for why the CPAP 
patients may have had more severe OSAS. 
Long-term follow-up
Few studies have investigated UPPP in the long-term perspective. A long-term 
study on 34 patients by Janson et al.136 used the success criteria of an at least 
50% reduction of the AHI and AHI < 10 and found that 12 of 25 (48%) were 
responders 4–8 years after UPPP surgery. A success factor in the study was a low 
preoperative AHI.
In a long-term follow-up by Värendh et al.,137 186 patients underwent pharyngeal 
surgery between 1985 and 1991, and were evaluated 19 to 25 years after surgery 
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with questionnaires, but without sleep recordings. The surgical technique was 
performed as described by Fujita, and cold steel was used in all cases, but 11 
patients where laser surgery was performed. About 50% of the patients were 
satisfied with the operation and one third had CPAP at the follow-up. A large 
proportion of the patients also reported side-effects. 
Previous RCT
The only known previous RCT of UPPP compared to expectancy is a study by 
Lojander et al.,138 in which 18 patients were randomised to UPPP (5 of them had 
an additional mandibular osteotomy) and 14 to expectancy. After one year the 
ODI
4
 changed significantly from 45 events/h sleep to 14 events/h sleep in the 
intervention group, compared to 34 events/h sleep to 23 events/h sleep in the 
control group, but the difference between the groups was not significant.  The 
results may be explained by the small study sample. 
Comparing compliance with treatment 
The compliance for UPPP is 100%, but the efficacy has been questioned.  In 
contrast, the efficacy of MRD and especially CPAP treatment when used pro-
perly is clear, but they are limited by their fairly low compliance. In a four-year 
follow-up of a randomised trial of MRD and UPPP, Walker-Engström et al. con-
cluded that the MRD group showed a significantly higher success rate regarding 
the AHI compared to the UPPP group, i.e., 72% compared to 35%, but that the 
effectiveness of the MRD was invalidated by a compliance rate of only 62%.139 
However, Weaver applied an intention-to- treat (ITT) analysis to the data from 
the Walker-Engström study.140 The purpose was to include all the drop-outs in 
the MRD group, as treatment adherence is not an issue with surgical therapy. 
When evaluating the laboratory success rates for MRDs, it was found to be 54% 
compared to 49% for UPPP in the ITT analysis, i.e., no significant difference. 
Additionally, Weaver argued that the sleep recording values obtained while pa-
tients wore the MRD during the sleep recording night should be corrected for 
the actual usage in everyday life in order to measure the full effectiveness of the 
treatment.  
Tracheostomy
Tracheostomy is an upper airway bypass procedure and was first introduced as 
treatment for patients with the most severe apnoea syndrome. Today it is only 
recommended when other treatment alternatives do not exist.120 In many cases, 
these patients are obese. 
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Success rate
Tracheostomy is highly effective, as shown by Guilleminault et al. in a one-year 
follow-up study of 50 tracheostomised OSAS patients, with a success rate of 
100% (apnoea index < 5).141 In this study, also the central apnoeas were reduced 
and daytime sleepiness was improved. In contradiction, there are studies that 
report that although the obstructive events decreased after tracheostomy, some 
patients had an increased number of central apnoeas.142, 143 Tracheostomy can 
also improve the subjective quality of life.144 
Long-term follow-up
In a retrospective study by Thatcher et al. of 79 OSA patients who had undergone 
tracheostomy between 1979 and 1999, it was concluded that the procedure was 
100% effective in terms of nocturnal respiratory disturbances and well tolerated 
in these severe OSA patients after a mean follow-up time of 8 years.145
Complications and adverse events
As an elective treatment, tracheostomy is a procedure for which the patient can 
be prepared, but the immediate postoperative risks are respiration-related ones, 
haemorrhage and infections. The long-term adverse effects are stoma granula-
tion, excessive mucotic secretion, respiratory tract colonisation and recurrent 
infections.141 Tracheostomy may also have an impact on daily life and social 
activities. However, it has also been shown that tracheostomy in patients with 
other diseases does not lead to a reduced QoL.146 
Mortality
In a study by Partinen and colleagues, patients with severe OSAS who had a 
tracheostomy or weight reduction were investigated.147 At the five-year-follow-
up the mortality was 0 of 71 patients in the tracheostomy group and 14 of 127 in 
the weight reduction group. Compared to CPAP, tracheostomy did not result in 
a higher mortality in an 8-year follow-up study by He et al.148 In the retrospec-
tive study by Thatcher et al. described above 14 deaths were identified.145 Five 
deaths were cardiopulmonary-related, four were from cancer, two were from 
postoperative complications of unrelated surgery and one was from aspiration. 
Tracheostomy-related mortality included one postoperative myocardial infarc-
tion and one tracheal-innominate fistula. 
Other upper airway surgical techniques for treating OSAS 
Woodson et al. investigated coblation of the soft palate in an RCT. There were 
no significant differences in the AHI between the intervention and the control 
groups.149 
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LAUP is a laser-assisted modification of the conventional uvulopalatoplasty (UPP, 
without tonsillectomy). It involves bilateral vertical incisions directly along both 
sides of the uvula and laser ablation thereof. A meta-analysis of LAUP showed an 
AHI reduction of 32%, comparable to 33% in UPPP,124 but LAUP has not been 
approved for OSA treatment according to the AASM because of insufficient evi-
dence of efficacy.150  
Solely tonsillectomy as OSAS treatment in adults has been shown to be effective in 
a study of seven patients, five of whom underwent tonsillectomy.151 In another study 
of nine OSAS patients by Verse et al., the success rate was 80% in patients with 
severe OSA (defined as a decrease in the postoperative AHI ≥ 50% and a postope-
rative AHI < 20).152  
There are numerous other surgical procedures for treating OSAS: for example, 
maxillomandibular advancement, genioglossus advancement and rapid maxillary 
expansion, which will not be further discussed in this thesis. 
   
HYPOTHESES AND AIMS
Hypothetical questions for the four papers were:
1. Is elective tracheostomy a tolerable and efficient treatment in selected OSAS 
patients?
2. Is UPPP an efficient and safe treatment in OSAS patients in the long-term 
perspective? 
3. Are the respiratory events during sleep significantly reduced in selected pa-
tients with OSAS treated with UPPP compared to expectancy for six months?
4. Are the subjective and objective parameters of EDS and quality of life signifi-
cantly improved and correlated in selected OSAS patients treated with UPPP 
compared to expectancy for six months?
The overall aim of this thesis was to evaluate subjective and objective outcomes of 
upper airway surgery in OSAS patients. 
The specific aims for the four papers were: 
1. To describe the tolerability of elective tracheostomy using custom-made tu-
bes, as well as the effects on daytime sleepiness and nocturnal respiration in 
obese patients with severe OSAS. 
2. To investigate the efficacy of UPPP treatment after 15 years, objectively with 
sleep apnoea recordings and subjectively with questionnaires regarding sa-
tisfaction, daytime sleepiness, pharyngeal side effects and snoring. Also, to 
compare the mortality rate in patients operated upon with that in the normal 
population.
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3. To evaluate nocturnal respiration using polysomnography in moderate-to-
severe OSAS patients after UPPP compared to the six-month expectancy 
(delayed surgery) in an RCT (SKUP3). 
4. To compare UPPP treatment with expectancy (RCT SKUP3), according 
to changes in EDS measured with questionnaires and vigilance tests, as 
well as the quality of life, and, furthermore, to perform correlation tests of 
changes in outcomes, also using respiratory parameters. 
SUBJECTS AND METHODS
SUBJECTS
PAPER 1
This was a retrospective descriptive study of tracheostomised patients with 
OSAS who attended the Department of ORL at the Karolinska University Hos-
pital Huddinge between 2002 and 2007. Inclusion criteria were (1) acceptance 
of elective tracheostomy, (2) failure of or not accepting treatment with CPAP or 
a bi-level pressure device (BiPAP), (3) a score of > 10 on the ESS or severe mor-
ning drowsiness and (4) a high ODI
4
 score, indicating a severe degree of OSAS. 
Ten patients, all males, met the inclusion criteria. Seven of these male patients 
had hypertension, five had suffered from stroke or myocardial infarction and 
four had diabetes mellitus. The only patient with an ESS < 10, complained about 
a marked morning drowsiness, in combination with insulin-resistant diabetes 
mellitus. Table 1 shows the baseline characteristics of the patients included in 
the study.
Table 1. Baseline characteristics of the 10 patients studied     
     
       Time to  
Patient Age in BMI  ESS ESS  ODI ODI first follow Clinical outcome
 years before before after before after up sleep 
       registration
       (months) 
  
1 61 45 13 6 73 70    1 Decannulated after 3 months, CPAP
2 49 45 17 0 55 13    4 Decannulated after 5 months, CPAP
3 31 37 20 5 91 1    2 UPPP, decannulated after 26 months
4 42 35 22 6 99 14    3 UPPP, decannulated after 23 months, CPAP
5 63 50 19 3 85 87    23 Tube since February 2003
6 58 33 8 7 126 24    4 Tube since February 2006
7 77 37   61     4 Tube 60 months, until death
8 63 33 18 2 60 4    6 Tube since June 2002
9 45 42 23 0 77 3.5    3 Tube since May 2003
10 43 31 11 7 100 2.5    6 Tube since April 2007
Median  53.5 36 18 5 81 13    4 
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PAPER 2
This was a non-randomised observational study of 50 unselected consecutive 
patients with habitual snoring and subjective symptoms of OSAS (48 males and 
2 females) who underwent UPPP between 1985 and 1988 at the Department of 
ORL at Söder Hospital in Stockholm. The patients had previously been evalua-
ted at 6 months and 2 and 4 years postoperatively regarding EDS using a local 
questionnaire and renewed sleep apnoea recordings.125, 126 The present study was 
the long-term follow-up of the same cohort. 
The median age at inclusion was 49 years (range 38–71), BMI was 30 (20–43) 
and the median ODI
4
 was 26.5 (4–82). Among the 50 patients, 8 had no EDS, 
11 mild, 21 moderate and 10 severe EDS at baseline according to responses to 
a question as to what degree they experienced subjective EDS. One patient with 
moderate EDS had a baseline ODI
4
 value of only 4. However, as the patient had 
undergone all previous follow-ups, he was also included in this study. 
PAPERS 3 AND 4
This was a randomised controlled study, RCT. At the start it was a two–centre 
study (see below), but soon thereafter it became a single-centre RCT of 65 OSAS 
patients (59 men and 6 women) referred consecutively to the ORL Department 
of the Karolinska University Hospital at Huddinge, Stockholm, Sweden, from 
June 2007 to May 2011 for possible UPPP. All patients had undergone screening 
ambulatory PG prior to the first visit to a physician. Examinations by an ORL 
physician included nasoscopy, flexible fibre endoscopy of the upper airways and 
staging of tonsil size (scale 0–4), as well as tongue position (scale 1–4), leading 
to the Friedman staging system.103  
The patients underwent a first full-night in-lab PSG. The morning after, they fil-
led in questionnaires and underwent a vigilance test (modified Osler). If the stu-
dy criteria were still satisfied, they were included in the study by randomisation. 
The inclusion criteria were: (1) males and females > 18 years of age, (2) AHI ≥ 
15 events/h sleep (from PSG), (3) ESS score ≥ 8, (4) excessive daytime sleepi-
ness three times a week or more, a single selected question from the BNSQ, (5) 
BMI < 36 kg/m2, (6) Friedman stage I or II  and (7) failure of CPAP and MRD 
treatments and no use of these treatments during the last three months. Patients 
with Friedman stage I and BMI < 30 kg/m2 did not have to have failed CPAP/
MRD treatment before inclusion.
The exclusion criteria were: (1) serious psychiatric, cardiopulmonary or neuro-
logical disease or an American Society of Anesthesiologists (ASA) classification 
> 3, (2) patients negative to surgery, (3) insufficient knowledge of Swedish, (4) 
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nightshift workers, (5) patients who could be dangerous in traffic, (6) severe 
nasal congestion (could be included after local treatment), (7) previous tonsil-
lectomy, (8) Friedman stage III and (9) severe clinical worsening of the OSAS 
during the study. For baseline characteristics see table 2.
There were six women in the study, and only three patients with Friedman stage 
I and a BMI < 30 kg/m2 who had not failed CPAP and MRD treatment before 
inclusion. At PSG 1, eight patients had a moderate OSAS with an AHI of 15 
to 29.9 events/h sleep, and 57 patients had a severe OSAS with an AHI ≥ 30 
events/h sleep. Sixteen of 32 patients had Friedman stage I and 18 of 32 had 
tonsillar hypertrophy (sizes 3 and 4)103 in the intervention group. Corresponding 
figures for the control group were 13 of 33 and 17 of 33. 
To increase the external validity, a two-centre study was initially developed: the 
ORL outpatient clinics at Karolinska University Hospital, sites Huddinge and 
Solna. At the start of this study, these sites were two separate clinics but, during 
the study, were fused into one, and all OSAS patients were allocated to site Hud-
dinge. Subsequently, there were only a total of four patients included from the 
Solna site. As all four deviated from the study protocol for different reasons and 
because of the low statistical power at this centre, we were urged by the statisti-
cians to exclude these patients, as well as the centre itself. Accordingly, all parti-
cipants in this study were recruited from site Huddinge as a single-centre study.
Table 2. Baseline characteristics in each group      
  
Characteristic n= Intervention n=  Control           
Age  32 41.5 (11.5)  33     42.9 (11.7)
Body mass index (BMI) (kg/m2) 32 28.2 (2.9)  33     27.7 (3.3)
Tonsil size 32 2.5 (0.8)  33     2.3 (0.9)
Friedman stage 32 1.5 (0.5)  33     1.6 (0.5)
Apnea Hypopnea Index (AHI) (events/h sleep) 32 53.3 (19.7)  33     52.6 (21.7)
Oxygen desaturation index (events/h sleep) 32 44.6 (23.5)  33     41.1 (22.2)
Nadir of oxygen saturation (%) 32 79.9 (5.3)  33     81.0 (6.6)
Arousal index (events/h sleep) 32 64.0 (16.2)  33     60.3 (22.7)
Epworth Sleepiness scale (ESS)  32 12.5 (3.2)  33     12.9 (3.1)
SF-36 physical functioning (PF) 32 83.7 (19.2)  33     87.0 (18.4)
SF-36 role physical  (PR) 32 69.5 (36.3)  33     75.8 (39.3)
SF-36 bodily pain (BP) 32 78.3 (27.1)  32     80.9 (23.0)
SF-36 general health (GH) 32 61.3 (24.1)  33     59.8 (23.9)
SF-36 vitality (VT) 32 42.8 (22.0)  33     42.3 (21.9)
SF-36 social functioning (SF) 32 74.2 (23.3)  33     77.3 (22.4)
SF-36 role emotional (RE) 32 77.1 (36.6)  33     81.8 (34.5)
SF-36 mental health (MH) 32 71.8 (19.3)  33     66.1 (18.8)
SF-36 physical component summary (PCS) 32 47.3 (8.6)  32     49.2 (8.9)
SF-36 mental component summary (MCS) 32 42.5 (10.7)  32     41.2 (10.1)
Sleep latency (minutes)  27 30.7 (11.1)  29     33.6 (9.0)
The above data are the mean (sd). n = number of patients
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METHODS 
PAPER 1 
Outcomes
The primary outcome was tolerability of the custom-made tube for more than six 
months. Other outcomes were changes in the ESS and the ODI
4
. 
Custom-made cannula 
The National Respiration Centre 
(NRC) was started in 1982 and is clas-
sified by the Swedish National Board 
of Health and Welfare as a national re-
ferral clinic for patients with chronic 
respiratory disorders. The clinic has a 
unique team of doctors specialised in 
ORL and anaesthesia and nurses and 
technicians. The NRC manufactures 
custom-made tubes and provides care-
ful preoperative information, as well 
as postoperative support, for each patient.153 The tubes were exclusively designed 
at the NRC for each patient with regard to material, thickness, length, curvature, 
position of the window, quality of stoma, the need for an inner tube, ability for 
speech and the patient’s requests.153 All patients with a tube underwent monthly 
follow-ups of their stoma at the NRC. Figure 8.
Epworth Sleepiness Scale
The ESS questionnaire was distributed during the medical consultations at the 
clinic and in connection with the sleep recordings.
Sleep apnoea recordings
Ambulatory polygraphy recordings were made with the use of the Embletta 
(Medcare Flaga, Reykjavik, Iceland) and the MicroDigitrapper (Synectics Medi-
cal, Stockholm, Sweden). The ODI
4
 was determined. The AHI measured by the 
thermistor, and in some patients also oro-nasal flowmetry, was not considered to 
be a consistently reliable measure of the airflow at this time and was therefore 
excluded. All recordings were interpreted by specialists in neurophysiology.
Figure 8. A custom-made tube designed at 
the National Respiration Centre, Paper 1.
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PAPER 2
Outcomes
The primary outcome was changes in ODI
4
. Other outcomes were the evaluation 
of questionnaires concerning EDS, satisfaction and pharyngeal symptoms and 
subjective and objective evaluations of snoring, as well as the mortality rate.
Surgical method of conservative uvulopalatopharyngoplasty 
The patients underwent conservative UPPP, including tonsillectomy, using a 
cold-steel technique. The mucosa from the anterior soft palate and anterior ton-
sil pillar was reduced by approximately 2–3 mm, and in the upper lateral corner 
by 3–4 mm. The mucosa between the anterior and posterior pillars was remo-
ved. The posterior tonsil pillar was preserved. The uvula was cut to a width and 
length of approximately 1 cm. An extracapsular tonsillectomy was performed 
with a sharp elevator. The posterior pillar was lifted up laterally and sewn up to 
the anterior pillar with separate inverted sutures. In the upper lateral corners, two 
or three sutures also included fibres from the palatopharyngeal muscle. Finally, 
the soft palate and the uvula were sutured. (Figure 9)
Figure 9.  
Schematic picture of conservative 
UPPP used in Paper 2.
Figure 10. 
Schematic picture of modified UPPP 
used in Papers 3 and 4.
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Sleep apnoea recordings and laboratory criteria for success
Ambulatory sleep apnoea recordings, using the same equipment and approach as 
at baseline and at the previous follow-ups, were used. Patients who had additive 
treatment (CPAP or MRD) did not use it during the night of the sleep recording. 
From the PG recordings, the ODI
4
 was measured, and also sound (decibel, dB) 
measurements were performed using the digitised Apnolog system (C-A Tegner 
Inc., Stockholm, Sweden). Sleeping time was estimated manually from the mo-
vement recording by one of the investigators, who was blinded to the patient’s 
subjective symptoms. 
The percentage of the estimated total sleep time (TST) during which respiratory 
sounds exceeded 40 dB was calculated, and if the time was above 40%, the pa-
tient was objectively classified as a snorer. 
The success criteria for recordings were ODI
4
 < 20 and a reduction of at least 
50% compared with baseline, as well as no more than 10 desaturations below 
90% during 6 hours of sleep.
Questionnaires
(A)  A locally developed questionnaire concerning satisfaction, EDS and sub-
jective snoring. The questions were: ’Are you satisfied with the UPPP sur-
gery?’ (Yes/No), ‘Do you regret the UPPP surgery?’ (Yes/No), ’Would you 
recommend UPPP surgery to others?’ (Yes/No/Do not know), ’Do you 
snore?’ (Never/Sometimes/ Often/Always) and ’How would you estimate 
your daytime sleepiness compared to before UPPP surgery?’ (Cured/Bet-
ter/Unchanged).
(B)  A questionnaire concerning pharyngeal symptoms such as vivid, queasy 
feelings, globus sensation and trouble with swallowing (for details, see 
Lundkvist et al.55) The 10 questions were answered on a four-point Likert 
scale in the order none, mild, moderate, severe, with a maximum symp-
tom score of 30. This questionnaire had not been validated, but four of 
the questions have been used in a previous study by Levring-Jäghagen.66 
This questionnaire had not been used previously on this cohort of OSAS 
patients.
(C)  ESS88 was used only at this 15-year follow-up.
Drop-out and subgroup analyses
Drop-outs were defined as patients not answering the 15-year questionnaires. 
Further subgroups were ‘living’ or ‘deceased’, as well as those who made sleep 
apnoea recordings or did not.
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PAPERS 3 AND 4
Outcomes
Paper 3: The primary outcome was changes in the AHI measured by PSG. Other 
outcomes were changes in other respiratory and sleep parameters.
Paper 4: Changes in the ESS questionnaire. Other outcomes were changes in the 
SF-36 questionnaire and changes in sleep latency from a vigilance test measu-
rement using a modified OSLER test. Further outcomes were from correlation 
tests for changes in subjective and objective data. 
Another outcome was changes in the BNSQ ’excessively sleepy’ question, but 
this result was considered to be excessive and was not reported in Paper 4, but 
it is in this thesis.
Intervention
Patients were randomised to receive either UPPP within one month or no treat-
ment at all for seven months. After the second evaluation with PSG, the patients 
in the control group also underwent UPPP. All patients were instructed to main-
tain their weight, to avoid new medicines and were restricted from other OSAS 
treatments during the study. 
Surgical method of modified uvulopalatopharyngoplasty 
All patients underwent UPPP under general anaesthesia using a nasal tube at the 
ORL Department of Karolinska University Hospital, site Huddinge. Local anaes-
thesia was administered before the surgery. The surgical procedure was carried 
out using the cold-steel technique and included tonsillectomy. On the advice of 
Associate Professor Per Olle Haraldsson the procedure had been slightly modi-
fied since a previous study from our group to minimise the risk of side-effects.122 
In this study the excisions of the soft palatal mucosa were performed only late-
rally to the uvula, which was only reduced (modified UPPP) (Figure 10). A total 
of eight different surgeons, all ORL specialists, performed the UPPPs.
Safety
All the patients who underwent UPPP were included in our safety programme, 
described earlier by our group;122 and directly after extubation they were transfe-
rred to the postoperative care unit for 6–24 hours of observation, depending on 
the severity of their condition. Additionally, all patients received perioperative 
penicillin prophylaxis, and postoperatively for three days. Two modifications of 
the safety programme were made before this study: perioperative cortisone and 
peri- and postoperative tranexamic acid were given for five days. 
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Polysomnography
Respiratory and sleep parameters were measured at baseline and six months 
after intervention or expectancy by an in-lab, full-night PSG, using the same 
Embla technology (Flaga Medical; Reykjavik, Iceland). Measurements were in-
terpreted manually by a single blinded scorer. The patients were awakened at 6 
a.m. due to the fact that the sleep laboratory located in a day-care unit. Sixteen 
channels were recorded: EEG (sensors C3-A2, O1-A2, O2-A1, C4-A1), EOG 
(left and right), EMG chin and tibialis (left and right), oronasal thermistor and 
flowmetry, transcutaneous oxygen saturation, respiratory movements (abdomen 
and thorax), snoring, ECG, pulse and body position. Parameters were defined 
according to AASM 2007 using criteria B for the hypopnoea.81 The patients were 
also informed that, before PSG nights, they should not have travelled abroad th-
rough more than two time zones during the last three weeks or consumed theine 
or caffeine during the afternoon and evening before PSG.
Sample size
The sample size was chosen to obtain 90% power with an α level of 5% and 
resulted in a total of 64 patients. The sample size calculation was based on the 
night-to-night variability of the ODI values in patients with OSAS154 and also 
on findings from one of our previous studies on patients with OSAS undergoing 
UPPP.122 
Randomisation
Stratified randomisation within four strata was used. Group A: Friedman stage 
I and BMI < 30 kg/m2; B: Friedman stage II and BMI < 30 kg/m2; C: Friedman 
stage I and BMI 30–35.9 kg/m2; D: Friedman stage II and BMI 30–35.9 kg/m2. 
Sixty-five randomised patients followed the study protocol and fulfilled all crite-
ria; see Figure 11. Altogether, 71 patients were randomised. After randomisation, 
the researchers discovered that two patients did not meet all the inclusion criteria 
and they were therefore excluded. Four patients were also excluded owing to 
deviation from the study protocol.
Epworth sleepiness scale 
The ESS questionnaire was distributed in connection with the PSG recordings.
Health Survey SF-36
The health survey SF-36 questionnaire was distributed in connection with the 
PSG recordings.
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Vigilance test
A modified OSLER test was performed. The patients performed the test once 
(instead of four times), directly after the in-lab PSG night. At study start the first 
seven patients performed the vigilance test in a different room from the one used 
later in the study. The research nurse who assisted the patients in the vigilance 
test was blinded to the patient group. The patients were not allowed to consume 
caffeine, theine or alcohol before the vigilance test (modified OSLER). 
Basic Nordic Sleep Questionnaire
In the RCT study, we selected a single question (in the following called ‘Excessi-
vely sleepy’) from the BNSQ93: Question no. 9, with the score 1 to 5; see below.
Do you feel excessively sleepy during the daytime? 
1. Never or less than once per month
2. Less than once per week
3. On 1-2 days per week
4. On 3-5 days per week
5. Daily or almost daily 
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STATISTICAL ANALYSES
PAPER 1
No statistical analysis was performed owing to the small number of subjects.
PAPER 2
Wilcoxon matched-pairs (WMP) tests were used to compare the results befo-
re and after surgery and Mann-Whitney U (MWU) tests for unpaired tests of 
drop-out and subgroup analyses. Correlation analyses were performed using 
Spearman’s rank correlation (SRC) tests. The software programme Statistica 6.0 
was used.
Standardised mortality ratio (SMR) calculations: the cohort was followed from 
the date of surgery up to the date of death or 31 December 2008, whichever oc-
curred first. The expected mortality in the patient group was estimated by split-
ting the person-years of follow-up according to the attained age in 5-year age 
bands and calendar years, and multiplying these by the corresponding sex-speci-
fic mortality rate in the general population. The overall and circulatory disease-
specific mortality rates were obtained from the Swedish Cause of Death Regis-
ter. The SMR was calculated by dividing the observed number of deaths by the 
expected number. The 95% confidence interval (CI) for the SMR was calculated 
assuming that the observed number of deaths follow a Poisson distribution. 
PAPER 3
Changes within groups were calculated by subtracting the outcomes from PSG 
1 from those from PSG 2, presented as the mean and standard deviation (sd). 
Changes between groups were presented as the mean and 95% CI. Since the 
sample size was over 30, parametric statistical analyses were used, and we also 
checked the distribution. Paired t-tests were used to compare the differences 
between PSG 1 and PSG 2 in each group, and unpaired t- tests were used to 
compare the changes between the two groups. All 65 participants were analysed 
in the per protocol analysis. 
There were no drop-outs, and the sensitivity analysis with ITT was performed 
with the 65 patients together with the six excluded patients. Missing values for 
these patients were imputed by using their baseline values + 1. Also for analyses 
of different subgroups, t-tests were used due to the normal distribution. All sta-
tistical calculations were performed using Statistica 10.0.
PAPER 4
Changes within groups were calculated by subtracting the outcomes at the first 
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recording in connection with PSG 1 from those in PSG 2. Because of the nature 
of the questionnaire parameters and the skewed distribution of the vigilance, 
non-parametric statistical analyses were chosen: p values from the Wilcoxon 
signed-rank (WSR) test for within-group comparisons and p values from inde-
pendent samples between group comparisons, MWU tests. For correlations bet-
ween changes in ESS, SF-36, vigilance and PSG parameters, a non-parametric 
SRC test was used. 
For ESS scores, a sensitivity analysis with ITT was performed including the six 
excluded patients.  Missing values were imputed by using the baseline values 
+0.5. Non-parametric tests were used, as above. Paired and unpaired t tests were 
also performed to investigate whether the results changed with parametric sta-
tistical methods. 
A Kaplan-Meier analysis was performed for all patients who had vigilance data at 
the follow-up. The vigilance test (time to fall asleep) was completed six months 
after intervention compared to no treatment. Patients who remained awake for 
40 minutes were censored. The difference between intervention and control was 
tested using the log-rank test. The Kaplan-Meier analysis is not reported in Paper 
4, but in this thesis.
All statistical calculations were performed using Statistica 10.0 or R ver. 2.15. 
ETHICAL PERMISSION
All participants in all studies gave their informed consent.  Studies 1 and 2 were 
approved by the Swedish Local Ethics Committee. Studies 3 and 4 were first re-
jected by the Swedish Regional Ethics Committee and, after an appeal, approved 
by the Central Ethics Committee.
RESULTS 
TRACHEOSTOMY (PAPER 1)
Results
Eight of 10 patients tolerated the tube more than six months. Two patients in-
sisted on decannulation due to respiratory problems during sleep, severe cough 
and infections. Thereafter, they were treated with CPAP again. Two additional 
patients were decannulated; they underwent UPPP one year after tracheostomy 
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and were thereafter successfully decannulated with normalised ODI
4
 values. 
One of these two patients had a dramatically reduced weight and required no ad-
ditional treatment. The other one had high ODI
4
 values one year after UPPP and 
was therefore treated with CPAP again. 
One patient with persistently high ODI
4
 values despite the tube was offered in-
vasive CPAP (CPAP connected to the tube). One patient had to use a ventilator 
during the first months after tracheostomy because of hypercapnoea. Neither his 
daytime sleepiness nor his ODI
4
 was normalised and he was therefore offered an 
invasive CPAP. However, he experienced the tube to be highly beneficial, with 
less severe morning drowsiness, and was not motivated to use an invasive CPAP. 
One of the patients died of cancer while still having his tube and therefore did 
not undergo the evaluation with postoperative sleep recordings and questionn-
aires. Three patients were complete responders and were still using their tubes 
with no additional treatment, and with normalised values for the daytime sleepi-
ness score, as well as for the ODI
4
. (Figure 12)
The ESS score was reduced from a median of 18 (range 8–23) to 5 (0–7) and the 
ODI
4
 values from 81 (55–126) to 13 (1–87). (Table 1)
Severe cough, sputum infections and stoma granuloma were seen in all patients. 
None of the patients had serious postoperative bleeding or any other serious 
complication. There was no mortality associated with the tracheostomy. 
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UPPP 15-YEAR FOLLOW-UP (PAPER 2)
Results
The median follow-up time was 189 months (15.75 years) (range 183–219 
months). At follow-up 13 patients had died. Twenty-six of the 37 living patients 
underwent postoperative sleep apnoea recordings. In the per protocol analysis, 
the median ODI
4
 had significantly decreased from 26.5 (range 4–82) to 8.5 
(range 0–60), p < 0.01, figure 13.  The mean ODI
4
 was reduced from 31.8 to 
15.4, a reduction of 52%. Seventeen out of 26 (65%) of the patients fulfilled the 
success criteria. Thirteen of these 17 patients were also classified as successes at 
the four-year follow-up. With a stricter success criteria (50% reduction and ODI
4
 
< 10) 14 of 26 patients (54%) were successes at the 15-year follow-up. 
With regard to objective snoring, 9 of 26 patients (35%) were categorised as non-
snorers and for subjective snoring 13 of 32 (40%) rated ’never’ or ’sometimes’. 
There was no correlation between subjective and objective snoring. However, a 
significant correlation between the ODI
4
 and the percentage of objective snoring 
during the estimated total sleep time was found: p < 0.05.
The median BMI was unchanged between baseline, 30 (20–43) kg/m2, and 15 
years, 30 (22–42) kg/m2.
Figure 13. Box-plots showing the oxygen desaturation index 4% (ODI
4
) 
values in the 26 patients who underwent sleep recordings, at baseline 
and different follow-ups at 6 months and 2, 4 and 15 years. Note the sig-
nificant difference between baseline and 15 years in ODI
4
, ** P < 0.01 
(Wilcoxon-matched pair tests).
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The questionnaires were answered by 32 of the 37 living patients (86%). In the 
per protocol analysis, twenty-five of 32 patients (78%) were satisfied with the 
surgery, but four regretted it. Twenty-three of 32 patients (72%) stated that they 
would recommend the surgery to another person. The results for EDS over the 
15 years are presented in Figure 14. At the follow-up, the median ESS value 
was 6 (range 0–19) and the median pharyngeal disturbances value was 3 (range 
0–10). 
Altogether, eight patients had complementary treatment at the 15-year follow-
up (CPAP, MRD or mandibular surgery). Five of these eight (62%) were still 
satisfied with UPPP, and also rated themselves as being better concerning EDS. 
Their median 15-year ODI
4
 value was 19 (8–39). Among the patients without 
any complementary treatment (n = 24), the corresponding values were 20 (83%) 
satisfied and 23 (96%) had EDS improvement and their median 15-year ODI
4 
value was 5.5 (0–60). 
In the mortality analysis we had a prolonged observation period of, in total, 18.2 
years up to 31 December 2008, thus approximately 3 years extra observation 
time. We noted 18 deaths during a total of 908 person-years of follow-up. The 
expected number of deaths, assuming that this cohort had the same mortality as 
the general population, was calculated to be 13.6, corresponding to an SMR of 
Figure 14. The rating of changes in excessive daytime sleepiness (EDS) among the 
included patients at evaluations after 6 months (m) as well as after 2, 4, and 15 years 
(y) after UPPP surgery for OSAS.
Cured
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1.32 (95% CI, 0.78–2.09). Thus, no significantly elevated mortality compared to 
the general population could be observed. Ten of the deaths were due to circula-
tory diseases, yielding a cause-specific SMR of 1.72 (95% CI, 0.83–3.17).  
Because of the high drop-out rate for both questionnaires and sleep recordings, 
subgroup analyses were performed for the baseline values. Concerning the ques-
tionnaires there were no significant differences in baseline values for age, BMI, 
ODI
4
, or nadir SaO
2
. However, the patients who dropped out were in median 9 
years older than those who filled in the questionnaires. The subgroup analyses of 
the postoperative ODI
4 
values at 6 months, 2, 4 and 15 years between living and 
deceased subjects, as well as between those who performed sleep recordings and 
those who did not, showed small and non-significant differences. 
SKUP3 RCT POLYSOMNOGRAPHIC RESULTS (PAPER 3)
Results
All 65 patients, 32 in the intervention group and 33 in the control group, comple-
ted the trial. The median period between PSG 1 at baseline and PSG 2 at follow 
up was 7.2 months (range 4.8–14.6) for the intervention group and 6.7 months 
(range 4.8–8.5) for the control group. 
The mean AHI in the intervention group had significantly decreased (p < 0.001) 
by 60%, from a mean (sd) of 53.3 (19.7) to 21.1 (16.7) (Figure 15). In the control 
group, the mean AHI decreased non-significantly, by 11%, from 52.6 (21.7) to 
46.8 (22.8), with a significant difference between the groups, p < 0.001. Similar 
results in favour of the intervention group were found in other respiratory para-
meters, as well as the arousal index, but not for other sleep parameters; see Table 
3. The mean reduction of ODI
3
 after UPPP was 69%.
The success rate for AHI (defined as ≤ 20 and a reduction of ≥ 50%) in the inter-
vention group was 19 of 32 (59%) and for the control group 2 of 33 (6%). The 
success rates for ODI
3
 and RDI (≤ 20 and a reduction of ≥ 50%) in the interven-
tion group were 21 of 32 (66%) and 15 of 32 (47%), respectively. In the control 
group, the success rates for the ODI
3
 and RDI were 3 of 33 (9%) and 1 of 33 
(3%), respectively. Fifteen of 32 patients in the intervention group were cured 
or had mild disease according to the AHI at PSG 2, compared to 1 of 33 in the 
control group (Figure 16). 
Furthermore, analyses of the subgroups showed that, independently of the BMI 
group, tonsil size or Friedman stage, the differences in AHI reduction were signi-
ficant in favour of the intervention group, except for tongue position 3 (Table 4).
56
Nanna Browaldh, 2013
57
Upper airway surgery in obstructive sleep apnoea.......
The percentage of sleep time in the supine position was elevated from a mean 
of 39% to 45% (6%) in the intervention group but was unchanged in the control 
group at PSG 2, compared to baseline. The BMI remained stable in both groups: 
no change in the intervention group and an increase of 0.4 kg/m2 in the control 
group. 
The ITT analysis, in which all parameters in Table 3 were calculated for the 71 
randomised patients, did not change the results compared to the per protocol 
analysis with 65 patients.
In total, six of 32 patients had non-serious complications. Four had pro-
longed duration of pain treated with various analgesics, and two patients had 
Figure 15. Boxplots and lines showing the apnoea-hypopnoea index (AHI) on two dif-
ferent polysomnography occasions (before and after) in the intervention group (grey) and 
the control group (white), respectively. Boxes represent the median, 25% and 75% values, 
whiskers the non-outlier range and dots represent the outliers. p Values represent the chan-
ges within groups (paired t-tests).
Figure 16. 
Number of patients in intervention group (n=32) and control group (n=33) at polysomno-
graphy (PSG) 1 and PSG 2, respectively.
Apnoea-hypopnoea index (AHI): cured <5, mild=5-14.9, moderate=15-29.9, severe ≥ 30
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postoperative bleeding and were treated medically. One had a night of observa-
tion in hospital three days after surgery. There were no serious complications or 
mortality. No patient was excluded owing to serious clinical impairment.
SKUP3 RCT DAYTIME SLEEPINESS AND QUALITY OF 
LIFE (PAPER 4)
Results
All 65 participants completed all ESS questionnaires, and the results were ana-
lysed in the available data analysis (per protocol). The median ESS had signifi-
cantly decreased from 12 (range 8–21) to 6 (2–16) (p < 0.001) in the intervention 
group, with a mean reduction of 5.7 (sd 3.9). The corresponding change for the 
control group was non-significant, from a median of 13 (8–18) to 12 (5–21), a 
significant difference between the groups (p < 0.001) (Figure 17, Table 5). 
The SF-36 questionnaires were completed by 65 participants. Three patients fai-
led to respond to one, two or three domains, respectively. In the intervention 
group, all domains showed improvements, and they were statistically significant 
for RP, GH, VT, SF and MH, as well as MCS and PCS. Changes in the con-
trol group were non-significant, and significant changes between the two groups 
were seen in GH, VT, SF, MCS and PCS (Table 5)
In the vigilance tests, only 48 of 65 patients had complete data (baseline and 
follow-up), with a drop-out rate of 26%. However, 57 patients had complete 
follow-up data, with a drop-out rate of 12%. In the available data analysis, the 
median sleep latency in the intervention group was significantly changed from 
38.4 min (range 11–40) to 40 min (16–40), (p = 0.013), a median difference of 
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Figure 17. Results for Epworth Sleepiness Scale (A) and ‘excessively sleepy’ question (B) 
for the intervention and the control group, respectively. Boxes represent the median and 25% 
and 75% values, whiskers the non-outlier range and dots the outliers. P-values represent the 
changes within groups, WSR test.
A. Box plots and lines showing the Epworth Sleepiness Scale (ESS) on two different 
polysomnography occasions (before and after) in the intervention group (grey) and the 
control group (white), respectively. 
B. Box plots and lines showing the ‘excessively sleepy’ question on two different poly-
somnography occasions (before and after) in the intervention group (n=31)(grey)  
and the control group (n=32)(white), respectively.
p-value n.s.
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1.6 min and a mean change of 7 (12.4) min. Before intervention, 9 out of 22 
(41%) patients passed the vigilance test, but, at follow-up, 20 of 22 patients 
(91%) passed the 40-minute test. In the control group, the median sleep latency 
remained unchanged with 40 min (15.5–40) at baseline and 40 min (3.65–40) 
at the follow-up. In the control group, 16 of 26 (62%) of the patients passed the 
vigilance test at baseline and 15 of 26 (58%) at the follow-up. The difference in 
sleep latency between the two groups was significant: p = 0.011.
The Kaplan-Meier analysis of the sleep latency from vigilance tests with data 
at the follow-up for 27 patients in the intervention group and 30 in the control 
group showed a significant difference between the two groups: log-rank test, p = 
0.0182; see Figure 18. 
For the correlation analysis, the mean changes (sd) for all 65 patients between 
follow-up and baseline data were used. The parameters for nocturnal respiration 
from PSG were as follows: AHI, -18.8 (24.9), nadir of oxygen saturation, 3.1 
(6.2) and arousal index, -16.2 (23.1).
There were significant correlations between changes in ESS and changes in the 
AHI (Figure 19), nadir of oxygen saturation, arousal index, the SF-36 domains 
SF, VT and MCS, and sleep latency (Table 6). In addition, there were significant 
Figure 18. Survival analysis with data at the follow-up for 27 patients in the interven-
tion group (the upper curve) and for 30 patients in the control group (the lower curve), a 
significant difference between the two groups, log-rank test, p = 0.0182.
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Figure 19. Correlation between changes in Epworth sleepiness scale (ESS) and in 
apnoea-hypopnoea index (AHI), n=65. P=0.001, Spearman’s rank correlation (SRC 
test), R=0.389. Transparent dots for intervention group and filled dots for control group.
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correlations between changes in ESS, VT and SF and sleep latency, respectively. 
Reversely, there was a significant negative correlation between RE and sleep 
latency, R = -0.33, p = 0.024; Table 6. 
Sixty-three patients responded to the ’excessively sleepy’ question and were in 
the available data analysis, with 1 drop-out in each group. The median value 
had decreased from 5 (4–5) to 3 (1–5) in the intervention group (p < 0.001) and 
had changed non-significantly in the control group from a median of 5 (4–5) to 
5 (2–5), also with a significant difference between the two groups (p < 0.001), 
see Figure 17.
The ITT analysis for all 71 randomised patients for the ESS did not change the 
results compared to the per protocol analysis comprising 65 patients. t-tests sho-
wed no significant differences compared to the non-parametric results presented 
in Table 5.  
DISCUSSION
OSAS is a general health problem that causes daytime sleepiness, an impaired 
quality of life and increased morbidity and mortality. Since there are many pa-
tients who do not accept or adhere to treatments with CPAP and/or MRD, there 
is a need for effective alternative surgical treatments.
Tracheostomy
In Paper 1 the major finding was that in selected patients with severe OSAS and 
obesity, tracheostomy may be an alternative treatment. Furthermore, trachesto-
my was tolerable in the majority of patients. The patients in this study received 
a custom-made tube and careful information, support and regular follow-ups, 
which may have influenced the results. However, in studies where individualised 
tubes were not made, similar tolerability has been reported.141, 143, 145 
All patients improved their daytime sleepiness measured with the ESS ques-
tionnaire. One explanation for this reduction of sleepiness might be fewer deep 
desaturations and a decreased time of oxygen tension lower than 90% after 
tracheostomy, which could be observed in three of these patients. However, there 
are many other studies showing divergent results between objective and subjec-
tive outcomes.76 
Previous studies have shown that tracheostomy is effective in terms of noctur-
nal breathing and mortality.141, 147 The finding that the ODI
4
 was not normalised 
in five patients despite the tracheostomy by-pass may be explained by the fact 
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that they were still obese. They might have had an undiagnosed OHS, which 
can co-exist in patients with OSAS. Unfortunately, blood-gas samples were not 
obtained in these patients. Some obstructive apnoeas may have changed into 
central apnoeas instead, as also found by Haapaniemi et al.144 The patients with 
persistently high ODI
4 
values did not accept invasive CPAP (ventilator attached 
to the tube) treatment, which may reflect lower motivation for additional tre-
atment because of improved daytime symptoms. This highlights the need for 
postoperative follow-up recordings, including blood gas samples and also eva-
luations of the need for assisted ventilation.
An additional finding in the present study was that tracheostomy served as a link 
to other treatments, for example, UPPP surgery, weight reduction or the use of 
CPAP again. The tracheostomy might improve the patients’ understanding of 
their OSAS disease, and therefore these patients may be better motivated for 
another attempt with non-surgical treatments. Some suitable patients could be 
offered other OSAS surgery, which should be performed while they still have 
their tubes in place to maintain a secure airway. Also in the study by Thatcher 
et al., it was found that a few of the 79 studied patients underwent decannula-
tion because of switching to CPAP treatment, resolution of OSA after UPPP and 
weight loss.145 
Paper 1 has some limitations; the design was retrospective with a small number 
of patients, which made it difficult to draw general conclusions. Further PG and 
not PSG recordings were performed, and the nasal flowmetry or a thermistor was 
not considered reliable at the start of the study. Therefore, changes in the ODI
4
 
instead of the AHI were chosen as the outcome. In addition, follow-up data are 
missing for one patient who died of cancer. Finally, the fact that only custom-
made tubes were used and the regular follow-ups at the NRC may have affected 
the results in a positive way. 
The strengths of the study are that it reflects the difficult clinical situation for 
patients with severe OSAS who have had failed non-surgical treatments. We also 
consider it a strength that the study emphasises the need for a careful preopera-
tive investigation of possible additional diseases and postoperative recordings, 
as well as an evaluation of the occurrence of hypercapnoea and the need for ad-
ditional ventilator treatment. 
Uvulopalatopharyngoplasty
Our main findings from the UPPP studies are that there was a significant diffe-
rence in respiratory parameters, as well as daytime sleepiness, after UPPP com-
pared to before surgery. The SKUP3 showed that these outcomes, as well as 
the quality of life, differed significantly in the intervention group, compared to 
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controls, in favour of the intervention group. Also, the ODI
4
 remain reasonably 
stable over time, as well as the symptoms of daytime sleepiness. 
According to the 15-year follow-up after UPPP (Paper 2), the success rate ac-
cording to the ODI
4
 was 17 out of 26 (65%) in the per protocol analysis. As 
reported earlier by Larsson et al., who had a higher number of follow-ups, the 
success rate was 30/50 (60%) after 6 months, 19/49 (39%) after 2 years and 
24/48 (50%) after 4 years.125, 126 In the SKUP3 (Paper 3), the success rate for the 
ODI
3
 was 66%. Furthermore, the mean AHI reduction in the intervention group 
was 60%, compared to 11% in the control group. Also patients with severe AHI 
values at baseline showed significant reductions of the respiratory parameters. 
Our results can also be compared with those from a previous study by our group 
comprising 158 OSAS patients undergoing UPPP.122 The results showed a simi-
lar success rate (50% reduction and ODI
4 
< 20) of 64%, compared to the present 
study of 65% in the 15-year follow-up and 66% in the SKUP3. Furthermore, a 
later analysis of the 158 patients in the study by Lundkvist et al. showed a mean 
reduction of the ODI
4
 of 60%,122 compared with mean reduction of ODI
3
 of 69% 
in the SKUP3 . Also, the mean AHI reduction of 60% after UPPP in the SKUP3 
can be compared with those from other centres reported in a recently published 
meta-analysis of 15 cohort studies after UPPP with a wide range and a mean 
AHI reduction of 33%.124 Our success rates are better than those of most centres, 
which might be explained by the use of different surgical techniques and/or dif-
ferent selections of patients.
Although the respiratory parameters changed significantly in the SKUP3 study, 
surprisingly, we did not find any significant differences in the other sleep quality 
parameters, i.e., total sleep time, percentage of rapid eye movement (REM) and 
N3 stage sleep and sleep efficiency, between the two groups. A slight improve-
ment in the percentage of deep and/or REM sleep would have been expected 
in the intervention group. However, the restricted sleep time, with wake-up at 
6 a.m., may have influenced these results, especially in those who are used to 
sleeping longer in the mornings, a time when most of the REM normally occurs. 
Furthermore, the baseline values were mainly within the normal range, without 
the possibility of large-scale improvement. On the other hand, the mean total 
arousal index decreased in favour of the intervention group. Sleep fragmentation 
caused by arousals is considered to be a major factor in daytime symptoms.155 
The apnoea index decreased significantly, but the hypopnoea index was not re-
duced in the same marked way. Furthermore, there was a significant increase in 
the mean RERA index after UPPP, compared to the control group. These findings 
are in accord with a conclusion drawn in a review by Sher et al.156 and could be 
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explained by the hypothesis that UPPP only partially increases the airflow, the-
reby transforming an apnoea (90% flow reduction) to a hypopnoea (50% reduc-
tion) and a hypopnoea to an RERA (< 30% reduction). 
When evaluating the excessive daytime sleepiness, the median ESS score after 
UPPP was 6 in the 15-year follow-up and, in the SKUP3 (Paper 4), the median 
ESS score was halved from 12 to 6 and the mean ESS deceased from 12.5 to 
6.8 in the intervention group. These results are identical to those from the 1-year 
follow-up of 158 OSAS patients.122 The ESS results are also similar to those 
reported by Yaremchuk et al., where the mean ESS score was reduced by 5.6 
after UPPP (in some patients including radiofrequency ablation of the tongue),91 
compared to a mean reduction of 5.7 in this RCT. Our results are also compa-
rable to those in a meta-analysis of CPAP or MRD treatments, where the mean 
ESS results decreased from 12.4 to 8.1 and 11.4 to 9.0, respectively.8 Also the 
’excessively sleepy’ question from the BNSQ showed a significant improvement 
in the UPPP group compared to the controls. It must also be remembered that 
the cut-off limit for inclusion in the present study was ESS ≥ 8 of a maximum 
of 24 and, for the ‘excessively sleepy’ score ≥ 4 of a maximum of 5. This may 
have influenced our results since it precluded a large improvement, especially 
for ’excessively sleepy’. However, the cut-off limit for ESS in the SKUP3 was 
chosen to be in the lower interval of the cut-off for mild EDS.88, 157 The 15-year 
follow-up (Paper 2) showed that 28 of 32 (88%) were ’better’ or ’cured’ concer-
ning EDS, indicating both a stable EDS and ODI
4
, although the large number of 
drop-outs after 15 years weaken the result. 
Our vigilance test in the SKUP3 (Paper 4) was a modified Osler test, but it sho-
wed a significant mean improvement of 7 minutes in sleep latency after UPPP. 
This could be compared to the results from a meta-analysis including patients 
with severe OSAS which showed that CPAP therapy improved the mean sleep 
latency measured with the MWT significantly by only one minute, compared to 
placebo.158 However, as there were only 22 of the 32 treated patients who under-
went the test before and after UPPP, our results should be taken with caution. 
Because of the number of missing data for individual changes in the vigilance 
test, a Kaplan-Meier analysis for sleep latency at follow-up was performed. Also 
this test revealed significant differences between the two groups. 
In order to understand EDS and other symptoms in OSAS, it is important to 
also look beyond the respiratory disturbances and consider the role of obesi-
ty and metabolic activity.12, 72 Furthermore, there are many other different fac-
tors that could have an impact on daytime sleepiness and the QoL. This risk is 
especially pronounced in long-term follow-ups such as in Paper 2. However, 
the short follow-up time of six months in Papers 3 and 4 may minimise such 
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possible changes. Again, it cannot be excluded that the outcome in the self-re-
ported questionnaires may be affected by the placebo effect of surgery and recall 
bias. However, the objective vigilance tests as well as PG and PSG, are less 
sensitive to placebo effects, and these investigations showed the same pattern as 
the questionnaires. 
In Paper 2, there was a surprisingly high satisfaction rate of 78% and few 
regrets, considering the very long follow-up period, which may reflect the fact 
that the majority of the patients considered themselves improved in their symp-
toms. Subjectively, the majority had improved or cured EDS and were satisfied. 
Our results are well in line with those of another Swedish long-term follow-up 
study137 of 186 patients who had undergone UPPP, in which only 66 of 129 
(51%) patients who had completed the questionnaire were satisfied with their 
treatment. As described by the authors, UPPP was performed according to Fu-
jita.121 The cold knife technique was used in all but 11 patients, in whom the 
laser technique was performed. Also, a phoniatric investigation was performed 
prior to surgery to determine how much of the soft palate could be removed. The 
satisfaction rates of the patients did not differ between the surgical techniques 
in their study. The reasons for the different results from ours could be that they 
underwent a more radical surgical technique.
The results from Paper 2 concerning subjective snoring showed that 13 of 32 
(40%) rated this as ’never’ or ’sometimes’. Regarding objective snoring from 
the PG recording, 9 of 26 patients (35%) were categorised as non-snorers at the 
follow-up. Furthermore, the results showed that the level of success for snoring 
was quite low, but this did not seem to influence the satisfaction rating. Also, 
even among the patients who had complementary treatment (CPAP, MRD or 
mandibular surgery), the majority were satisfied with the surgery.
Regarding the quality of life, compared to the general Swedish population, the 
patients in SKUP3 (Paper 4) had a lower subscale score on the SF-36, especially 
on RP, GH, VT and SF, but it increased to normal or less subnormal values for 
the present age group after UPPP.159 Many studies show significant adverse ef-
fects of sleep apnoea on the patients’ quality of life, but also that CPAP treatment 
improves the SF-36 scores, especially on RP, GH, VT and SF.114, 160, 161 
The SKUP3 study (Paper 4) showed significant correlations between changes in 
subjective and objective outcomes, also with nocturnal respiration. There were 
significant correlations between changes in ESS and the AHI and the nadir of 
oxygen saturation, as well as the arousal index, suggesting that the improved 
quality of sleep and respiration increase the self-reported EDS, and that the ef-
fect may be caused by UPPP. Also, the objective vigilance test showed signifi-
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cant correlations between changes in ESS and sleep latency, as well as changes 
between the AHI and GH, VT and SF. This can be compared to the findings of 
Bennett et al.,161 in which 51 patients with SDB were evaluated concerning the 
quality of life measured with the SF-36 before and after CPAP treatment. PSG 
was performed at baseline. Significant associations were found between AHI 
and arousals and change in the VT and PR. Furthermore, sleepiness measured 
with the ESS and OSLER correlated significantly with the pretreatment values 
of the SF-36 domain VT. 
An inconsistent finding in our study was the negative significant correlation bet-
ween changes in sleep latency and the SF-36 domain role emotion (RE). This 
may be explained by the fact that the three patients with the most impaired sleep 
latency had improvements in RE. On the other hand, the finding of few im-
provements in some aspects of the quality of life in the expectancy group is 
not unexpected, as all patients were part of a study and probably felt cared for. 
However, the findings that three SF-36 domains, GH, VT, and SF, all showed 
highly significant differences between groups in favour of UPPP, are important 
and consistent. 
 
Significant correlations between the SF-36 and the degree of OSAS,77, 78 as well 
as between the respiratory disturbance index and the ESS,74 have been demon-
strated previously. To the best of our knowledge, the UPPP findings with correla-
tions for changes in the PSG parameters, daytime sleepiness symptoms and qua-
lity of life, respectively, have not been reported previously in adults with OSAS. 
The results concerning postoperative subjective pharyngeal symptoms in Paper 
2 showed that the pharyngeal symptoms after UPPP are mild even in long-term 
aspects (median value of 3 of maximum 30). The results are comparable to the 
ones in the study by Lundkvist et al., in which the median score was 5 one year 
after UPPP.55 Jäghagen et al. have performed objective measurements (videora-
diography) of the swallowing process before and after pharyngeal surgery, and 
preoperative pharyngeal swallowing dysfunction was not shown to predict the 
development of dysphagia after surgery.162 There have been reports of large per-
centages of dysphagia and globus sensation in UPPP patients,163 but the surgical 
techniques have changed over time, making the reports confusing. Often a mix-
ture of different methods has been used and the reports are therefore difficult to 
interpret. However, at our centre, a similar conservative technique using cold 
steel with a one-stage procedure has been performed throughout the years and 
further modified in 2007 at the start of SKUP3. 
In the SKUP3 (Paper 3), 6 of 32 patients had non-serious complications, two of 
which (6%) were postoperative bleeding and were treated medically. The fact 
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that no patients  had severe complications may be the result of our safety pro-
gramme, which was supplemented with cortisone and tranexamic acid, compa-
red to the previous study by Lundkvist et al. in 158 patients,122 with four (2.5%) 
intraoperative complications, mostly bleedings after tonsillectomy. As only 32 
patients so far have been evaluated concerning complications, the figures should 
be taken with caution, but further evaluation also of side-effects in all 65 patients 
is planned. 
The mortality after UPPP was investigated in Paper 2. The SMR indicated no 
increased mortality in this heterogeneous OSAS population, compared to the 
general population in Sweden. Several studies have indicated an approximately 
3–6 times increased mortality in untreated OSAS.3-5 One reason for the low mor-
tality rates in Paper 2 could be the fact that several patients were treated with 
CPAP, MRD or had additional mandibular surgery. Another speculative reason 
could be a protective role of having moderate OSAS at more advanced ages, as 
suggested by Lavie et al.70 It must not be ignored that UPPP could have a protec-
tive effect, as described by other authors.134 
The efficacy of UPPP in OSAS treatment has been questioned because of the 
lack of randomised studies.9 Furthermore, there has also been a call for research 
in RCTs of surgery other than UPPP and UPP because of the fear of a high risk 
of long-term side-effects,163 as discussed above. The only previous RCT of UPPP 
compared to expectancy is a study by Lojander et al., described above.138 The 
ODI
4
 changed significantly from 45 to 14 in the intervention group, compared 
to 34 to 23 in the control group, but the difference between the groups was not 
significant. The results may be explained by their small study sample. There 
are few other RCT studies on surgical intervention for OSAS. Woodson et al. 
conducted an RCT of blinded treatment in OSAS patients using a temperature-
controlled radiofrequency and Steward et al. with palatal implants of the soft 
palate, both compared to sham-placebo.149, 164 None of these studies were able to 
show any significant improvement in the AHI compared to control as was shown 
in the present SKUP3. The efficacy of UPPP compared to untreated controls in 
the present setting is hereby proven, even though further RCTs at other centres 
are needed.  
UPPP includes tonsillectomy per definition and has been a well-known surgi-
cal treatment for OSAS since it was first introduced in 1981.121 However, there 
are always difficulties when evaluating a two-stage treatment. In adults, studies 
evaluating tonsillectomy for OSAS are rare. One study of nine adult OSAS pa-
tients with large tonsils who underwent tonsillectomy showed an 80% success 
rate.152 Adult OSAS patients with large tonsils are few in number, only 6% ac-
cording to one study.35 The majority have a soft palate and uvula which has been 
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traumatised and deranged after several years of snoring and vibrations, leading 
to bulky tissue which obstructs the airway during sleep. The results from the 
study by Lundkvist et al. for 158 OSAS patients undergoing UPPP showed that 
young age, but not tonsil size was a success factor.122 In our experience, tonsil-
lectomy independently of tonsil size is important, as a part of UPPP in OSAS 
as it enables the lateralisation and suturing of the posterior tonsillar pillar, thus 
widening the airway space, which is supported by the results in Paper 3 and the 
study by Lundkvist et al.122 A meta-analysis of LAUP showed an AHI reduction 
of 32%, comparable to 33% in UPPP,124 indicating that the palatal resection also 
improves nocturnal respiration. 
The results of our studies show that UPPP could be offered to selected patients: 
Friedman stage I or II and BMI < 36, who have failed non-surgical treatments 
and have no contra-indications to surgery. Patients with a BMI of up to 40 have 
undergone UPPP at our clinic, as also reported in our previous study,122 and in a 
study by Friedman,104 as salvage procedure and after careful preoperative infor-
mation. To severe obese patients with Friedmans stage III, or stage IV (BMI>40), 
or with other severe co-morbidities, who have totally failed non-surgical treat-
ment, tracheostomy should be offered instead. For younger patients with Fried-
man stage I and BMI < 36, UPPP may be an option as a first line treatment. 
When discussing the efficacy of different treatment options for OSAS, it is of 
importance to consider the compliance in everyday life. Devices are only ef-
fective while they are used. CPAP treatment is often considered to be compliant 
when patients use CPAP ≥ 4 hours/night as an average over all nights observed. 
However, this may hide insufficient reductions of the AHI. When comparing 
non-optimal use of optimal CPAP therapy with the continuous effect (100% 
compliance) of often not optimal UPPP surgery, it would be more appropriate 
to compare the AHI according to a mean AHI over the night, also for CPAP. Ac-
cording to a study by Ravesloot et al.,165 the episodes without effective treatment 
indicate that patients with moderate OSAS reduce the AHI only by 33–48% 
when using CPAP 4 hours per night and those with severe OSA reduce their AHI 
by 42%. 
There has also been a worry as to whether UPPP influences future use of CPAP.166 
The surgical method used at the start in the 1980s and 1990s was more radical 
than it is today. The patients in the present studies had only minor resections of 
the soft palate and uvula, i.e., a modified UPPP. A small Chinese study compared 
the classical UPPP with a modified UPPP and noted that all the problems with 
CPAP titrations occurred in the group of classical UPPP patients.167 Based on our 
studies and clinical experience, patients who fail surgical treatment could return 
to CPAP or MRD and comply. 
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In all studies, especially in long-term follow-up studies as in Paper 2, there is 
always a risk of other changes: for example, in lifestyle or other treatments that 
may influence the results. In Paper 2 the median BMI did not change over the 
years, which might be explained by our clinical practice of informing all patients 
of the importance of a stable weight. Also in Papers 3 and 4, the mean BMI and 
mean time in the supine position were stable in both groups, and thus probably 
did not affect the results.
There are several limitations in Paper 2: firstly, the lack of a randomised control 
group and, secondly, a 15-year recall bias. Thirdly, a relatively small number of 
patients were subjected to the 15-year follow-up sleep apnoea recording, and no 
ITT analysis was performed. However, the very long follow-up quite naturally 
explains that 11 patients did not show up and that 13 were deceased. Altogether, 
the subgroup analyses indicated quite homogeneous groups at baseline, as well 
as stable and equal postoperative results of the sleep recordings throughout the 
years for all subgroups. Fourthly, the sleep apnoea recordings have clear weak-
nesses compared with the technology of today, since the AHI parameter was not 
measured at the Neurophysiological Department that we referred our patients to. 
During the 1980s, the available measuring technique with thermistors was not 
considered reliable in ambulatory monitoring. However, it is possible that oxy-
gen desaturations have a great impact on cardiovascular health.168 Fifthly, there 
was no wash-out period for the patients with CPAP and MRD. However, the 
subjective outcome did not show any major differences and the ODI
4
 was hig-
her than in the group without complementary treatment, as was expected. Other 
studies have shown that the majority of apnoeas relapse already during the first 
night without CPAP.169 Sixthly, the questionnaires used for EDS, satisfaction, 
snoring and pharyngeal symptoms have not been validated. Finally, we consider 
it a weakness that according to baseline parameters, 8 patients had no EDS and 1 
patient had an ODI
4
 value of 4. However, we cannot exclude the possibility that 
these patients suffered from other symptoms of OSAS.
The main limitations of Papers 3 and 4 are the missing data and drop-outs for 
the vigilance test in both groups, but also the fact that six patients were excluded 
after randomisation. On the other hand, these patients were allocated to separate 
groups, and sensitivity analyses were performed and did not affect the results. 
Furthermore, there is the short duration of only six months, but the researchers, 
as well as the Ethical Approval Committee, found it unethical to leave the pa-
tients in the control group untreated for a longer time. Also, the PSG was not 
performed on two following nights at each evaluation point. However, all pa-
tients had undergone ambulatory PG before the baseline in-lab PSG, which imp-
lies that the AHI limit of 15 or more for inclusion was valid. Another weakness 
in Paper 4 is that the MWT was not used. However, the MWT is resource and 
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time-demanding, and our patients did not receive any economic compensation 
for the time spent in the study, which explains a high drop-out rate, and also that 
we were only able to perform the vigilance test once per day (modified OSLER). 
Yet, another study showed that the four times repeated OSLER test during one 
day produces reproducible and stable results over time in OSAS patients.170 A 
further weakness is that the vigilance was performed in different rooms and was 
not evaluated with an error profile,170 which could have refined the assessment of 
the variations. It must be taken into account that the change in vigilance may be 
affected by the fact that the patients were censored at 40 minutes in the vigilance 
test. Altogether, the results from the vigilance tests must be interpreted with cau-
tion, although we cannot ignore the fact that our results are coherent.
The most important strength of Paper 2 is the very long-term follow-up, inclu-
ding sleep recordings. Furthermore, the majority of these patients have under-
gone four different follow-ups over the years, which enabled us to show consis-
tency in the results from sleep recordings. Also, considering the time period, the 
drop-out rate for the subjective measurement was quite low. Finally, the Swedish 
social security number register makes it possible to follow the study population’s 
mortality rates and causes.
The major strength of Papers 3 and 4 is the randomised, controlled design, but 
also the investigation of the OSAS patients with in-laboratory PSG, the applica-
tion of the ESS for subjective evaluation of daytime sleepiness and the use of an 
objective vigilance test, as well as the well-known SF-36 questionnaire. Further-
more, the PSG recordings were performed the night before the vigilance test, 
allowing assessment of the quality of sleep. Additionally, only a single person, 
blinded to patient grouping, interpreted all PSGs manually and there were no 
drop-outs for PSG data in the study. The most probable reason why no one drop-
ped out is that we encouraged the surgery patients on several occasions to com-
plete their follow-up. Another strength is that eight different surgeons performed 
the surgery, which means that the result is not dependent on a single surgeon. In 
addition, the correlation tests in Paper 4 showed statistical significance and that 
the results from subjective and objective symptoms of daytime sleepiness and 
from PSG are concordant. Furthermore, our main results in Paper 4 were verified 
by both parametric and non-parametric statistical methods and it was also veri-
fied that the ITT analyses in Papers 3 and 4 did not markedly change the results 
compared to the per protocol analyses. 
There is considerable evidence for OSAS being an anatomical disorder; pa-
tients with OSAS have an enlargement of the upper airway soft tissue structures, 
are often obese with an increased neck size and fat deposition along the up-
per airway, and several studies have also demonstrated a family aggregation of 
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craniofacial morphology.41 But there are also numerous arguments for obesity 
and its metabolic activity in development of OSAS.12 OSAS is probably a syn-
drome with many different faces. Nevertheless, the different treatment options 
serve to increase upper airway dimensions by altering upper airway anatomy. 
Management of the OSAS patient is challenging. In the clinic and daily handling 
of these patients, all treatment options, both non-surgical and surgical, should 
be regarded as a spectrum of possibilities. The options often supplement each 
other when customizing an often life-long treatment to each patient individually. 
Also, in patients failing upper airway surgery, additional treatments with MRD 
or CPAP appear to be feasible. 
The efficacy of UPPP in OSAS treatment has been questioned, as well as its very 
existence, because of a fear of side-effects and a lack of high-quality studies.9, 163 
In summary, the studies in this thesis show that there is a place for surgical tre-
atment options in OSAS and that modified UPPP can be both safe and effective 
compared to controls. Furthermore, the fact that a previous prospective cohort 
study of 158 OSAS patients at our centre, and the 15-year follow-up, showed 
very similar subjective and objective outcomes compared to this RCT, certainly 
strengthens the positive effect of modified UPPP. However, more RCTs at other 
centres are needed.
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GENERAL APPLICATIONS
In Paper 1, there were only 10 patients over a time period of five years who had 
tracheostomy for severe OSAS, indicating a very small and selected group of 
patients who are offered this treatment option, which makes general application 
difficult. The patients had standard tracheostomy surgery according to our clini-
cal routines, but the fact that only custom-made tubes were used may limit the 
generalisability. 
The study population in Paper 2 was heterogeneous concerning the degrees of 
severity of OSAS, the level of daytime sleepiness, obesity and cardiovascular 
co-morbidity. This could partly be explained by the fact that UPPP was practi-
cally the only available treatment for OSAS at the time, and it was offered to all 
in whom there was no major contraindication for surgery. At study start, this he-
terogeneous patient group most probably reflected the OSAS population eligible 
for surgical treatment at that time. 
Conversely, the general population of adult OSAS patients in Sweden today is 
not similar to the one in Papers 3 and 4. Firstly, the population in the SKUP3 
was at least 10–15 years younger and the majority had a BMI of less than 30 kg/
m2, much lower than the general adult OSAS population, also compared with a 
population having CPAP treatment.35, 116 Secondly, the SKUP3 does not address 
patients with Friedman stage III or OSAS patients with severe co-morbidity or 
a BMI ≥ 36 kg/m2. Furthermore, the SKUP3 was a single-centre study, and more 
centres are needed to enhance the generalisability.
The patients in Papers 1, 3 and 4 had not succeeded in complying with other 
alternative and non-surgical treatments, and the alternative to tracheostomy or 
UPPP was no treatment at all. Additionally, for all four studies, there were only 
few women. Consequently, the results of the present studies do not address all 
OSAS patients seen in general clinical practice. 
The general applicability in these four studies is, however, valid, as all studies 
reflect our daily clinical routines at the ORL department. Patients who fail or do 
not accept non-surgical treatments should be referred to ORL specialists for as-
sessment for upper airway surgery.  
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CONCLUSIONS
1. Elective tracheostomy was a tolerable and effective treatment in terms 
of daytime symptoms in a majority of selected patients with severe 
OSAS and served as a link to other treatments. Not all patients showed 
improvement in nocturnal respiration, and therefore postoperative sleep 
recordings are needed. 
2. UPPP was a stable and successful treatment after 15 years according to 
the reduction of nightly respiratory disturbances and daytime sleepiness 
symptoms, and no increased mortality was seen compared to the normal 
population. 
3. The RCT showed a highly significant and clinically relevant difference 
in respiratory disturbances in favour of UPPP, compared to expectancy, 
in selected OSAS patients. Also patients with small tonsils may benefit 
from surgery.
 4. The RCT showed a highly significant and clinically relevant reduction 
in daytime sleepiness and sleep latency, as well as improvement in the 
quality of life, in favour of UPPP, compared to expectancy in selected 
OSAS patients. Significant correlations between changes in subjective 
(questionnaires) and objective (vigilance and PSG data) outcomes were 
seen. 
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FUTURE PERSPECTIVES
This thesis has raised many new questions. 
Tracheostomy is a seldom used treatment option in patients with OSAS and the-
refore large randomised studies are difficult to perform. However, it is desirable 
to have future studies on the effect of tracheostomy and also to include measure-
ments of changes in the quality of life and changes in metabolic parameters, the 
occurrence of hypercapnoea and the need for additional ventilator treatment.
Even though there is increasing evidence concerning which patients we may be 
able to help or cure with UPPP, there are still many questions to be answered. 
Friedman’s staging system is helpful, but there are also more anatomical factors to 
take into account, for example, the constitution of the tonsillar pillars, uvula and 
the tongue base, as well as sites of collapse during sleep. It would be interesting to 
investigate whether further anatomical correlates will help to refine the assessment 
of which OSAS patients we should offer UPPP surgery or not. Also, more RCTs 
comparing tonsillectomy, UPP and UPPP are recommended to further clarify the 
question of which parts of the surgery, or if all parts, are necessary in all patients. 
Today, UPPP and other upper airway surgery methods are used primarily in pa-
tients who have rejected CPAP and other non-surgical treatments. With the know-
ledge of OSAS being a disease that may aggravate over time, should UPPP surgery 
be offered to younger patients as an early intervention to prevent the progression? 
In that case, which factors should predict an early recommendation of UPPP? A 
further step would also be to investigate the upper airway structure, respiratory 
airflow and breathing control, and also to determine which level of the obstruction 
site is the most important. Simulations of the airflow could also help to predict 
which patients will be cured and improved by upper airway surgery. Future studies 
with a multidisciplinary approach to investigating these more sophisticated diag-
nostic methods are both challenging and tempting. 
Another question is the gender factor. Is the success factor the same in females 
and males? Also, how important is BMI for surgical success? It would also be 
highly useful to evaluate how UPPP affects blood pressure and other metabolic 
parameters. Further research priorities are evaluations of respiratory parameters, 
side-effects, the risk of traffic accidents and mortality in the long-term perspective. 
Is the AHI a surrogate measurement for OSA? More studies to investigate correla-
tions of objective and subjective parameters are also needed.  
Finally, our hope is that this thesis can be the start of a continuous effort to elabo-
rate national standardised procedures for upper airway surgery in OSAS patients.
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POPULÄRVETENSKAPLIG SAMMANFATTNING
Obstruktivt sömnapnésyndrom (OSAS) hos vuxna är en folksjukdom med en förekomst 
på 4% hos män och 2% hos kvinnor. Patienterna har ofta uttalad snarkning samt and-
ningsuppehåll under sömn och får syrebrist och störd sömnkvalitet p.g.a. täta mikro-
uppvaknanden. Detta leder till dagsömnighet och högre utsöndring av stresshormoner 
med påföljande medicinska komplikationer, till exempel ökad risk för hjärtkärlsjuk-
dom, diabetes, trafikolyckor och en ökad dödlighet. Den största riskfaktorn för OSAS 
är fetma. Andra orsaker är avvikande anatomi i de övre luftvägarna, exempelvis stora 
halsmandlar, stor tunga, hängande gomsegel.
Idag är den vanligaste behandlingen för OSAS en övertrycks-mask s.k. CPAP, som pa-
tienten har framför ansiktet under sömn.  En alternativ behandling är en underkäks-
framdragande bettskena, s.k. MRD. Cirka hälften av patienterna som erbjuds dessa 
hjälpmedel använder det inte på ett optimalt sätt, exempelvis p.g.a. biverkningar eller 
otillräcklig effekt. Vidare har långtidsuppföljningar visat en följsamhet på endast ca 
50-70% av dessa icke-kirurgiska behandlingar. Därför har det alltid funnits ett behov av 
kirurgi som alternativ eftersom många patienter annars riskerar att förbli obehandlade.
Den första kända kirurgiska behandlingen av OSAS är tracheostomi, vilket innebär en 
alternativ luftväg direkt in i övre delen av luftstrupen och på så vis undviks de trånga 
partierna i svalget. Tracheostomi används idag som behandling för OSAS endast i sär-
skilt utvalda mycket svårbehandlade fall, som t.ex. kraftigt överviktiga med komplice-
rande sjukdomar. 
Från början av 80-talet började OSAS-patienter genomgå operation med svalgkirurgi, 
så kallad uvulopalatopharyngoplastik (UPPP), vilket innebär bortopererande av hals-
mandlar samt gomplastik. Metoderna, lyckandegraden samt biverkningsfrekvensen för 
denna operation har varierat genom åren.  En nordisk SBU rapport om OSAS från 2007 
kom fram till att det inte fanns tillräckligt med vetenskapligt stöd för om UPPP är ef-
fektivt som behandling av OSAS, då det saknades randomiserade kontrollerade studier 
(RCT), samt att det förelåg hög risk för svalg-biverkningar och komplikationer i sam-
band med kirurgin. Därför har det varit delade meningar om UPPP har en plats som 
behandling av OSAS. 
Denna avhandling studerar två kirurgiska behandlingsmetoder för OSAS; tracheostomi 
samt modifierad UPPP (skonsam kirurgisk teknik). 
I DELARBETE 1 utvärderade vi 10 patienter med grav OSAS och övervikt samt symp-
tom på dagsömnighet. Patienterna hade inte tolererat eller accepterat icke-kirurgisk 
behandling. Trachealkanylerna var individuellt utformade. 8 av10 patienter tolererade 
trachealkanylen mer än 6 månader. Vid uppföljningen hade alla patienter normaliserat 
sina dagsömnighetsvärden, men den uppföljande sömnregisteringen visade att 5 patien-
ter inte fick normaliserad andning under sömn, trots trachealkanylen. Det är viktigt med 
noggrann uppföljning för att fånga upp de patienter som behöver tilläggsbehandling.
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I DELARBETE 2 fortsatte vi utvärderingen av 50 patienter som opererats med UPPP 
pga OSAS 15 år tidigare. Vid denna långtidsuppföljning hade 13 patienter dött. Av res-
terande 37 levande patienter gjorde 26 stycken den uppföljande sömnregistereringen. 
Denna visade att antalet andningsstörningar  för gruppen var uttalat förbättrade jämfört 
med före operationen, och fortsatt låga. 32 av de 37 patienterna svarade på enkäter vid 
uppföljningen. Resultaten visade att även den subjektiva dagsömnigheten upplevdes 
som låg och stabil, samt att 78% av patienterna som svarade på enkäten var nöjda med 
operationen. Dödligheten för de opererade patienterna var inte ökad jämfört med den 
ålders- och köns-matchade normalbefolkningen i Sverige, vilket kan tyda på att UPPP 
har en viss skyddande effekt.
DELARBETE 3 är en randomiserad kontrollerad studie (RCT) kallad SKUP3 där 32 
patienter lottades till UPPP direkt (operationsgruppen) och 33 patienter till exspektans 
i 6 månader och fördröjd UPPP (kontrollgruppen). Patienter aktuella för studien hade 
alla BMI <36, samt stora halsmandlar, eller små halsmandlar i kombination med låg 
tungposition. För operationsgruppen var minskningen av antalet andningsstörningar per 
sömntimme 60%, och för kontrollgruppen 11%, en uttalad skillnad mellan grupperna. 
Övriga andningsparametrar följde samma mönster. Studien visade även att patienter 
som har små halsmandlar eller övervikt kan ha god behandlingseffekt av UPPP. Dessa 
fynd liknar dem från tidigare studier utförda av vår forskningsgrupp. Alla patienter kun-
de skrivas hem dagen efter operation. 6 av 32 opererade patienter fick lindriga kompli-
kationer, vilka kunde behandlas med vanliga läkemedel. 
DELARBETE 4 är en fortsatt utvärdering av SKUP3 med samma patientgrupp som i 
delarbete 3. I denna studie utvärderade vi dagsömnighet samt livskvalitet. Resultaten 
visade att operationsgruppen (UPPP) hade signifikant förbättrat sina subjektiva och ob-
jektiva dagsömnighetsvärden mätt med ett vakenhetstest. Dessutom upplevde patienter-
na bättre livskvalitet mätt med enkäten SF-36. För kontrollgruppen påvisades inte dessa 
förbättringar. Skillnader mellan grupperna var uttalade till operationsgruppens fördel. 
Sammanfattningsvis kan tracheostomi användas i vissa särskilt komplicerade fall. 
Långtidsuppföljningen visade att UPPP-effekten kvarstod över tid, både avseende and-
ningsstörningar samt dagsömnighet, och ingen ökad dödlighet påvisades. Modifierad 
UPPP visade sig vara effektiv både avseende förbättrad nattlig andning och dagsymtom, 
och ett alternativ för patienter med vissa anatomiska förutsättningar i svalget, där  icke-
kirurgisk behandling inte har fungerat. Vi rekommenderar att sådana patienter erbjuds 
bedömning av öron-näsa-hals-specialister för eventuell svalgkirurgi.
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